[10-Q] Perma-Fix Environmental Services, Inc. Quarterly Earnings Report
PESI鈥檚 Q2-25 10-Q shows clear operating improvement but profitability remains elusive. Net revenue rose 4.3% YoY to $14.6 m, driven by a 37% jump in Treatment segment sales that offset a 43% Services decline. Cost control cut COGS 14.7%, lifting gross margin to 10.6% from -9.3% last year; this produced the first quarterly gross profit ($1.5 m) in four quarters. SG&A (up 19.5% YoY) and R&D kept the firm in the red, yet the operating loss narrowed to $2.9 m (-43%). Net loss improved to $2.7 m (-$0.15/sh) vs $4.0 m (-$0.27/sh).
For 1H-25, revenue increased 3.3% to $28.5 m and gross profit swung positive to $2.2 m; net loss trimmed to $6.3 m. Cash fell to $22.6 m from $29.0 m at YE-24 as operations consumed $4.0 m and capex $1.5 m. Liquidity remains solid鈥攏o revolver borrowings and total debt dropped to $2.0 m (0.9脳 1H sales), leaving $25.4 m of availability under the credit facility. Working capital is still positive at $21.5 m.
Share count rose 30% YoY to 18.5 m following 2024 equity raises, diluting per-share metrics. Deferred revenue edged up 4% while unbilled receivables climbed 26%, signalling backlog conversion in 2H. Management met all PNC covenant thresholds and amended the facility to relax FCCR tests when liquidity exceeds $5 m.
Key takeaways:
- Gross margin inflection driven by higher Treatment mix and lower disposal/ subcontract costs.
- Cash burn moderating; balance sheet lightly levered.
- Services segment weakness and higher corporate SG&A temper recovery.
Il 10-Q del secondo trimestre 2025 di PESI mostra un chiaro miglioramento operativo, ma la redditivit脿 resta sfuggente. I ricavi netti sono aumentati del 4,3% su base annua, raggiungendo 14,6 milioni di dollari, grazie a un balzo del 37% nelle vendite del segmento Trattamenti che ha compensato un calo del 43% nei Servizi. Il controllo dei costi ha ridotto il COGS del 14,7%, portando il margine lordo al 10,6% rispetto al -9,3% dell'anno precedente; ci貌 ha generato il primo utile lordo trimestrale (1,5 milioni di dollari) dopo quattro trimestri. SG&A (in aumento del 19,5% su base annua) e R&S hanno mantenuto la societ脿 in perdita, ma la perdita operativa si 猫 ridotta a 2,9 milioni di dollari (-43%). La perdita netta 猫 migliorata a 2,7 milioni di dollari (-0,15 dollari per azione) rispetto a 4,0 milioni (-0,27 dollari per azione).
Per il primo semestre 2025, i ricavi sono cresciuti del 3,3% a 28,5 milioni di dollari e l鈥檜tile lordo 猫 diventato positivo, raggiungendo 2,2 milioni; la perdita netta si 猫 ridotta a 6,3 milioni. La liquidit脿 猫 scesa a 22,6 milioni da 29,0 milioni a fine 2024, poich茅 le operazioni hanno assorbito 4,0 milioni e gli investimenti 1,5 milioni. La liquidit脿 rimane solida: nessun prestito sul revolver e il debito totale 猫 sceso a 2,0 milioni (0,9脳 vendite del primo semestre), lasciando 25,4 milioni di disponibilit脿 sulla linea di credito. Il capitale circolante 猫 ancora positivo a 21,5 milioni.
Il numero di azioni 猫 aumentato del 30% su base annua a 18,5 milioni dopo le raccolte di capitale del 2024, diluendo i parametri per azione. I ricavi differiti sono cresciuti del 4%, mentre i crediti non fatturati sono saliti del 26%, segnalando una conversione dell鈥檃rretrato nella seconda met脿 dell鈥檃nno. Il management ha rispettato tutte le soglie dei covenant PNC e ha modificato la linea di credito per allentare i test FCCR quando la liquidit脿 supera i 5 milioni.
Punti chiave:
- L鈥檌nversione del margine lordo 猫 stata guidata da una maggiore incidenza del segmento Trattamenti e da costi inferiori di smaltimento e subappalto.
- Il burn di cassa si sta moderando; il bilancio presenta una leva finanziaria contenuta.
- La debolezza nel segmento Servizi e l鈥檃umento degli SG&A aziendali frenano la ripresa.
El informe 10-Q del segundo trimestre de 2025 de PESI muestra una clara mejora operativa, pero la rentabilidad sigue siendo esquiva. Los ingresos netos aumentaron un 4,3% interanual hasta 14,6 millones de d贸lares, impulsados por un salto del 37% en las ventas del segmento de Tratamientos que compens贸 una ca铆da del 43% en Servicios. El control de costos redujo el COGS en un 14,7%, elevando el margen bruto al 10,6% desde -9,3% el a帽o pasado; esto produjo el primer beneficio bruto trimestral (1,5 millones de d贸lares) en cuatro trimestres. Los gastos SG&A (aumentaron un 19,5% interanual) y de I+D mantuvieron a la empresa en n煤meros rojos, aunque la p茅rdida operativa se redujo a 2,9 millones (-43%). La p茅rdida neta mejor贸 a 2,7 millones (-0,15 d贸lares por acci贸n) frente a 4,0 millones (-0,27 d贸lares por acci贸n).
En el primer semestre de 2025, los ingresos aumentaron un 3,3% hasta 28,5 millones y el beneficio bruto se volvi贸 positivo con 2,2 millones; la p茅rdida neta se redujo a 6,3 millones. El efectivo cay贸 a 22,6 millones desde 29,0 millones a finales de 2024, ya que las operaciones consumieron 4,0 millones y la inversi贸n en capital 1,5 millones. La liquidez sigue siendo s贸lida: sin pr茅stamos revolventes y la deuda total baj贸 a 2,0 millones (0,9脳 ventas del primer semestre), dejando 25,4 millones de disponibilidad en la l铆nea de cr茅dito. El capital de trabajo sigue siendo positivo en 21,5 millones.
El n煤mero de acciones aument贸 un 30% interanual a 18,5 millones tras las ampliaciones de capital de 2024, diluyendo las m茅tricas por acci贸n. Los ingresos diferidos aumentaron un 4%, mientras que las cuentas por cobrar no facturadas subieron un 26%, se帽alando la conversi贸n del backlog en la segunda mitad del a帽o. La direcci贸n cumpli贸 con todos los umbrales de los convenios de PNC y modific贸 la l铆nea de cr茅dito para relajar las pruebas FCCR cuando la liquidez supera los 5 millones.
Puntos clave:
- El cambio en el margen bruto fue impulsado por una mayor proporci贸n del segmento de Tratamientos y menores costos de disposici贸n/subcontrataci贸n.
- La quema de efectivo se est谩 moderando; el balance tiene un apalancamiento ligero.
- La debilidad en el segmento de Servicios y el aumento de los gastos corporativos SG&A frenan la recuperaci贸n.
PESI鞚� 2025雲� 2攵勱赴 10-Q 氤搓碃靹滊姅 氇呿檿頃� 鞖挫榿 臧滌劆鞚� 氤挫棳欤检毵� 靾橃澋靹膘潃 鞐爠頌� 鞏措牑鞖� 靸來櫓鞛呺媹雼�. 靾滌垬鞚奠潃 鞝勲厔 雽�牍� 4.3% 歃濌皜頃� 1460毵� 雼煬搿�, 旃橂 攵�氍胳潣 毵れ稖鞚� 37% 旮夓頃橃棳 靹滊箘鞀� 攵�氍胳潣 43% 臧愳唽毳� 靸侅噭頄堨姷雼堧嫟. 牍勳毄 甏�毽 毵れ稖鞗愱皜(COGS)臧� 14.7% 臧愳唽頃橂┌ 齑濎澊鞚惦鞚� 鞛戨厔 -9.3%鞐愳劀 10.6%搿� 靸侅姽頄堦碃, 4攵勱赴 毵岇棎 觳� 攵勱赴 齑濎澊鞚�(150毵� 雼煬)鞚� 旮半頄堨姷雼堧嫟. 韺愲Г甏�毽箘(SG&A)電� 鞝勲厔 雽�牍� 19.5% 歃濌皜頄堦碃 鞐瓣惮臧滊皽牍�(R&D)霃� 鞙犾霅橃柎 鞝侅瀽毳� 旮半頄堨溂雮�, 鞓侅梾靻愳嫟鞚� 290毵� 雼煬(-43%)搿� 欷勳棃鞀惦媹雼�. 靾滌啇鞁れ潃 270毵� 雼煬(-欤茧嫻 0.15雼煬)搿� 臧滌劆霅橃柎 鞚挫爠 400毵� 雼煬(-欤茧嫻 0.27雼煬) 雽�牍� 順胳爠霅橃棃鞀惦媹雼�.
2025雲� 靸侂皹旮办棎電� 毵れ稖鞚� 3.3% 歃濌皜頃� 2850毵� 雼煬, 齑濎澊鞚奠潃 220毵� 雼煬搿� 頋戩瀽 鞝勴櫂頄堨溂氅� 靾滌啇鞁れ潃 630毵� 雼煬搿� 於曥唽霅橃棃鞀惦媹雼�. 順勱笀鞚� 2024雲� 毵� 2900毵� 雼煬鞐愳劀 2260毵� 雼煬搿� 臧愳唽頄堨溂氅�, 鞖挫榿鞐愳劀 400毵� 雼煬, 靹る箘韴瀽鞐愳劀 150毵� 雼煬臧� 靻岆霅橃棃鞀惦媹雼�. 鞙犽彊靹膘潃 瓴碃頃橂┌, 須岇爠雽�於� 彀瀰鞚� 鞐嗞碃 齑濍秬毂勲姅 200毵� 雼煬(靸侂皹旮� 毵れ稖鞚� 0.9氚�)搿� 臧愳唽頃� 鞁犾毄 頃滊弰 雮挫棎 2540毵� 雼煬鞚� 臧�鞖╈劚鞚� 雮晞 鞛堨姷雼堧嫟. 鞖挫爠鞛愲掣鞚� 鞐爠頌� 2150毵� 雼煬搿� 鞏戫樃頃╇媹雼�.
欤检嫕 靾橂姅 2024雲� 鞛愲掣 頇曥订 鞚错泟 鞝勲厔 雽�牍� 30% 歃濌皜頃� 1850毵� 欤茧 欤茧嫻 歆�響滉皜 頋劃霅橃棃鞀惦媹雼�. 鞚挫棸靾橃澋鞚� 4% 歃濌皜頄堦碃 氙胳箔甑� 毂勱秾鞚� 26% 靸侅姽頃� 頃橂皹旮� 靾橃＜ 鞛旉碃 鞝勴櫂鞚� 鞁滌偓頃╇媹雼�. 瓴届榿歆勳潃 氇摖 PNC 瓿勳暯 臁瓣贝鞚� 於╈”頄堨溂氅�, 鞙犽彊靹膘澊 500毵� 雼煬毳� 齑堦臣頃� 霑� FCCR 韰岇姢韸鸽ゼ 鞕勴檾頃橂弰搿� 鞁犾毄 頃滊弰毳� 靾橃爼頄堨姷雼堧嫟.
欤检殧 鞖旍爯:
- 齑濎澊鞚惦 氚橃爠鞚� 旃橂 攵�氍胳潣 牍勳 歃濌皜鞕� 韽愱赴/頃橂弰旮� 牍勳毄 臧愳唽鞐� 旮办澑頃╇媹雼�.
- 順勱笀 靻岇 靻嶋弰臧� 鞕勴檾霅橁碃 鞛堨溂氅�, 鞛 靸來儨電� 瓴诫頃� 霠堧矂毽 靸來儨鞛呺媹雼�.
- 靹滊箘鞀� 攵�氍胳潣 鞎届劯鞕� 歃濌皜頃� 旮办梾 SG&A臧� 須岆车靹鸽ゼ 鞝滌暯頃╇媹雼�.
Le rapport 10-Q du deuxi猫me trimestre 2025 de PESI montre une nette am茅lioration op茅rationnelle, mais la rentabilit茅 reste difficile 脿 atteindre. Le chiffre d'affaires net a augment茅 de 4,3 % en glissement annuel pour atteindre 14,6 millions de dollars, port茅 par une hausse de 37 % des ventes dans le segment Traitement, qui a compens茅 une baisse de 43 % dans les Services. Le contr么le des co没ts a r茅duit le co没t des marchandises vendues (COGS) de 14,7 %, faisant passer la marge brute 脿 10,6 % contre -9,3 % l'ann茅e pr茅c茅dente ; cela a g茅n茅r茅 le premier b茅n茅fice brut trimestriel (1,5 million de dollars) depuis quatre trimestres. Les frais SG&A (en hausse de 19,5 % en glissement annuel) et la R&D ont maintenu l'entreprise dans le rouge, mais la perte d'exploitation s'est r茅duite 脿 2,9 millions (-43 %). La perte nette s'est am茅lior茅e 脿 2,7 millions (-0,15 $ par action) contre 4,0 millions (-0,27 $ par action).
Pour le premier semestre 2025, le chiffre d'affaires a augment茅 de 3,3 % pour atteindre 28,5 millions et le b茅n茅fice brut est devenu positif 脿 2,2 millions ; la perte nette a 茅t茅 r茅duite 脿 6,3 millions. La tr茅sorerie est tomb茅e 脿 22,6 millions contre 29,0 millions 脿 la fin 2024, les op茅rations ayant consomm茅 4,0 millions et les investissements 1,5 million. La liquidit茅 reste solide : aucun emprunt sur la ligne de cr茅dit renouvelable et la dette totale a diminu茅 脿 2,0 millions (0,9脳 les ventes du premier semestre), laissant 25,4 millions de disponibilit茅 sur la facilit茅 de cr茅dit. Le fonds de roulement reste positif 脿 21,5 millions.
Le nombre d'actions a augment茅 de 30 % en glissement annuel pour atteindre 18,5 millions suite aux lev茅es de fonds de 2024, diluant les indicateurs par action. Les revenus diff茅r茅s ont progress茅 de 4 % tandis que les cr茅ances non factur茅es ont augment茅 de 26 %, signalant une conversion du carnet de commandes au second semestre. La direction a respect茅 tous les seuils des covenants PNC et a modifi茅 la facilit茅 pour assouplir les tests FCCR lorsque la liquidit茅 d茅passe 5 millions.
Points cl茅s :
- L鈥檌nflexion de la marge brute est due 脿 une plus grande part du segment Traitement et 脿 des co没ts de mise au rebut/sous-traitance plus faibles.
- La consommation de tr茅sorerie ralentit ; le bilan est l茅g猫rement endett茅.
- La faiblesse du segment Services et la hausse des frais SG&A freinent la reprise.
Der 10-Q-Bericht von PESI f眉r das zweite Quartal 2025 zeigt eine deutliche operative Verbesserung, doch die Profitabilit盲t bleibt schwer erreichbar. Der Nettoumsatz stieg im Jahresvergleich um 4,3 % auf 14,6 Mio. USD, angetrieben durch einen 37%igen Anstieg der Ums盲tze im Behandlungssegment, der einen R眉ckgang im Servicebereich um 43 % ausglich. Durch Kostenkontrolle wurde der COGS um 14,7 % gesenkt, was die Bruttomarge von -9,3 % im Vorjahr auf 10,6 % anhob; dies f眉hrte zum ersten viertelj盲hrlichen Bruttogewinn (1,5 Mio. USD) seit vier Quartalen. SG&A (plus 19,5 % im Jahresvergleich) und F&E hielten das Unternehmen weiterhin in den roten Zahlen, jedoch verringerte sich der Betriebsverlust auf 2,9 Mio. USD (-43 %). Der Nettoverlust verbesserte sich auf 2,7 Mio. USD (-0,15 USD pro Aktie) gegen眉ber 4,0 Mio. USD (-0,27 USD pro Aktie).
F眉r das erste Halbjahr 2025 stiegen die Ums盲tze um 3,3 % auf 28,5 Mio. USD, und der Bruttogewinn wurde mit 2,2 Mio. USD positiv; der Nettoverlust verringerte sich auf 6,3 Mio. USD. Die liquiden Mittel fielen von 29,0 Mio. USD Ende 2024 auf 22,6 Mio. USD, da der operative Betrieb 4,0 Mio. USD und Investitionen 1,5 Mio. USD verbrauchten. Die Liquidit盲t bleibt solide 鈥� keine revolvierenden Kredite und die Gesamtschulden sanken auf 2,0 Mio. USD (0,9脳 Halbjahresumsatz), was eine Verf眉gbarkeit von 25,4 Mio. USD unter der Kreditfazilit盲t l盲sst. Das Working Capital ist mit 21,5 Mio. USD weiterhin positiv.
Die Anzahl der Aktien stieg nach Kapitalerh枚hungen 2024 um 30 % auf 18,5 Mio., was die Kennzahlen pro Aktie verw盲ssert. Die abgegrenzten Ertr盲ge stiegen um 4 %, w盲hrend nicht fakturierte Forderungen um 26 % zunahmen, was auf eine Umwandlung des Auftragsbestands in der zweiten Jahresh盲lfte hindeutet. Das Management erf眉llte alle PNC-Kovenanten und 盲nderte die Fazilit盲t, um FCCR-Tests zu lockern, wenn die Liquidit盲t 5 Mio. USD 眉bersteigt.
Wichtigste Erkenntnisse:
- Die Wende der Bruttomarge wurde durch einen h枚heren Anteil des Behandlungssegments und geringere Entsorgungs-/Subunternehmerkosten getrieben.
- Der Cash-Burn verlangsamt sich; die Bilanz ist leicht verschuldet.
- Die Schw盲che im Service-Segment und die gestiegenen SG&A-Kosten bremsen die Erholung.
- Gross margin turned positive to 10.6% after four loss-making quarters.
- Operating loss narrowed 43% YoY and net loss improved 31%.
- No borrowings on $12.5 m revolver; total debt down to $2.0 m.
- Treatment segment revenue grew 37% YoY, indicating demand for core radioactive waste services.
- Company still posted a $2.7 m quarterly net loss and consumed $4.0 m cash from operations YTD.
- Cash balance fell 22% since year-end, reducing financial cushion.
- Services segment revenue dropped 43%, signalling market or execution issues.
- Share dilution of ~30% YoY from prior equity raises weakens per-share metrics.
Insights
TL;DR 鈥� Loss narrows; margin turns positive but cash burn persists.
Revenue beat modestly on Treatment strength, flipping gross profit positive. Operating metrics improved across the board: Q2 operating loss down 43%, 1H loss down 30%. Balance sheet is conservative鈥�$22.6 m cash, zero revolver use, <1脳 debt/EBITDA (still negative). However, 1H operating cash flow was -$3.8 m and cash is 22% below YE-24. Continued SG&A inflation and Services softness suggest breakeven is still several quarters away. Overall impact: neutral; trend is constructive but valuation hinges on proving sustained positive EBITDA.
TL;DR 鈥� Mix shift to high-margin Treatment is encouraging.
Treatment revenue rose 37% YoY and now accounts for 78% of sales, leveraging PESI鈥檚 unique radioactive waste permits. Fixed-price contracts dominated (97% of Treatment revenue), providing visibility. Deferred revenue up and unbilled receivables higher indicate pipeline health. Yet Services revenue collapse (-44%) highlights competitive pressure and federal budget timing. If Treatment utilization holds and Services stabilises, PESI could break even once corporate overhead is rationalised. Risk remains from contract lumpiness and regulatory exposure. Impact: slightly positive.
Il 10-Q del secondo trimestre 2025 di PESI mostra un chiaro miglioramento operativo, ma la redditivit脿 resta sfuggente. I ricavi netti sono aumentati del 4,3% su base annua, raggiungendo 14,6 milioni di dollari, grazie a un balzo del 37% nelle vendite del segmento Trattamenti che ha compensato un calo del 43% nei Servizi. Il controllo dei costi ha ridotto il COGS del 14,7%, portando il margine lordo al 10,6% rispetto al -9,3% dell'anno precedente; ci貌 ha generato il primo utile lordo trimestrale (1,5 milioni di dollari) dopo quattro trimestri. SG&A (in aumento del 19,5% su base annua) e R&S hanno mantenuto la societ脿 in perdita, ma la perdita operativa si 猫 ridotta a 2,9 milioni di dollari (-43%). La perdita netta 猫 migliorata a 2,7 milioni di dollari (-0,15 dollari per azione) rispetto a 4,0 milioni (-0,27 dollari per azione).
Per il primo semestre 2025, i ricavi sono cresciuti del 3,3% a 28,5 milioni di dollari e l鈥檜tile lordo 猫 diventato positivo, raggiungendo 2,2 milioni; la perdita netta si 猫 ridotta a 6,3 milioni. La liquidit脿 猫 scesa a 22,6 milioni da 29,0 milioni a fine 2024, poich茅 le operazioni hanno assorbito 4,0 milioni e gli investimenti 1,5 milioni. La liquidit脿 rimane solida: nessun prestito sul revolver e il debito totale 猫 sceso a 2,0 milioni (0,9脳 vendite del primo semestre), lasciando 25,4 milioni di disponibilit脿 sulla linea di credito. Il capitale circolante 猫 ancora positivo a 21,5 milioni.
Il numero di azioni 猫 aumentato del 30% su base annua a 18,5 milioni dopo le raccolte di capitale del 2024, diluendo i parametri per azione. I ricavi differiti sono cresciuti del 4%, mentre i crediti non fatturati sono saliti del 26%, segnalando una conversione dell鈥檃rretrato nella seconda met脿 dell鈥檃nno. Il management ha rispettato tutte le soglie dei covenant PNC e ha modificato la linea di credito per allentare i test FCCR quando la liquidit脿 supera i 5 milioni.
Punti chiave:
- L鈥檌nversione del margine lordo 猫 stata guidata da una maggiore incidenza del segmento Trattamenti e da costi inferiori di smaltimento e subappalto.
- Il burn di cassa si sta moderando; il bilancio presenta una leva finanziaria contenuta.
- La debolezza nel segmento Servizi e l鈥檃umento degli SG&A aziendali frenano la ripresa.
El informe 10-Q del segundo trimestre de 2025 de PESI muestra una clara mejora operativa, pero la rentabilidad sigue siendo esquiva. Los ingresos netos aumentaron un 4,3% interanual hasta 14,6 millones de d贸lares, impulsados por un salto del 37% en las ventas del segmento de Tratamientos que compens贸 una ca铆da del 43% en Servicios. El control de costos redujo el COGS en un 14,7%, elevando el margen bruto al 10,6% desde -9,3% el a帽o pasado; esto produjo el primer beneficio bruto trimestral (1,5 millones de d贸lares) en cuatro trimestres. Los gastos SG&A (aumentaron un 19,5% interanual) y de I+D mantuvieron a la empresa en n煤meros rojos, aunque la p茅rdida operativa se redujo a 2,9 millones (-43%). La p茅rdida neta mejor贸 a 2,7 millones (-0,15 d贸lares por acci贸n) frente a 4,0 millones (-0,27 d贸lares por acci贸n).
En el primer semestre de 2025, los ingresos aumentaron un 3,3% hasta 28,5 millones y el beneficio bruto se volvi贸 positivo con 2,2 millones; la p茅rdida neta se redujo a 6,3 millones. El efectivo cay贸 a 22,6 millones desde 29,0 millones a finales de 2024, ya que las operaciones consumieron 4,0 millones y la inversi贸n en capital 1,5 millones. La liquidez sigue siendo s贸lida: sin pr茅stamos revolventes y la deuda total baj贸 a 2,0 millones (0,9脳 ventas del primer semestre), dejando 25,4 millones de disponibilidad en la l铆nea de cr茅dito. El capital de trabajo sigue siendo positivo en 21,5 millones.
El n煤mero de acciones aument贸 un 30% interanual a 18,5 millones tras las ampliaciones de capital de 2024, diluyendo las m茅tricas por acci贸n. Los ingresos diferidos aumentaron un 4%, mientras que las cuentas por cobrar no facturadas subieron un 26%, se帽alando la conversi贸n del backlog en la segunda mitad del a帽o. La direcci贸n cumpli贸 con todos los umbrales de los convenios de PNC y modific贸 la l铆nea de cr茅dito para relajar las pruebas FCCR cuando la liquidez supera los 5 millones.
Puntos clave:
- El cambio en el margen bruto fue impulsado por una mayor proporci贸n del segmento de Tratamientos y menores costos de disposici贸n/subcontrataci贸n.
- La quema de efectivo se est谩 moderando; el balance tiene un apalancamiento ligero.
- La debilidad en el segmento de Servicios y el aumento de los gastos corporativos SG&A frenan la recuperaci贸n.
PESI鞚� 2025雲� 2攵勱赴 10-Q 氤搓碃靹滊姅 氇呿檿頃� 鞖挫榿 臧滌劆鞚� 氤挫棳欤检毵� 靾橃澋靹膘潃 鞐爠頌� 鞏措牑鞖� 靸來櫓鞛呺媹雼�. 靾滌垬鞚奠潃 鞝勲厔 雽�牍� 4.3% 歃濌皜頃� 1460毵� 雼煬搿�, 旃橂 攵�氍胳潣 毵れ稖鞚� 37% 旮夓頃橃棳 靹滊箘鞀� 攵�氍胳潣 43% 臧愳唽毳� 靸侅噭頄堨姷雼堧嫟. 牍勳毄 甏�毽 毵れ稖鞗愱皜(COGS)臧� 14.7% 臧愳唽頃橂┌ 齑濎澊鞚惦鞚� 鞛戨厔 -9.3%鞐愳劀 10.6%搿� 靸侅姽頄堦碃, 4攵勱赴 毵岇棎 觳� 攵勱赴 齑濎澊鞚�(150毵� 雼煬)鞚� 旮半頄堨姷雼堧嫟. 韺愲Г甏�毽箘(SG&A)電� 鞝勲厔 雽�牍� 19.5% 歃濌皜頄堦碃 鞐瓣惮臧滊皽牍�(R&D)霃� 鞙犾霅橃柎 鞝侅瀽毳� 旮半頄堨溂雮�, 鞓侅梾靻愳嫟鞚� 290毵� 雼煬(-43%)搿� 欷勳棃鞀惦媹雼�. 靾滌啇鞁れ潃 270毵� 雼煬(-欤茧嫻 0.15雼煬)搿� 臧滌劆霅橃柎 鞚挫爠 400毵� 雼煬(-欤茧嫻 0.27雼煬) 雽�牍� 順胳爠霅橃棃鞀惦媹雼�.
2025雲� 靸侂皹旮办棎電� 毵れ稖鞚� 3.3% 歃濌皜頃� 2850毵� 雼煬, 齑濎澊鞚奠潃 220毵� 雼煬搿� 頋戩瀽 鞝勴櫂頄堨溂氅� 靾滌啇鞁れ潃 630毵� 雼煬搿� 於曥唽霅橃棃鞀惦媹雼�. 順勱笀鞚� 2024雲� 毵� 2900毵� 雼煬鞐愳劀 2260毵� 雼煬搿� 臧愳唽頄堨溂氅�, 鞖挫榿鞐愳劀 400毵� 雼煬, 靹る箘韴瀽鞐愳劀 150毵� 雼煬臧� 靻岆霅橃棃鞀惦媹雼�. 鞙犽彊靹膘潃 瓴碃頃橂┌, 須岇爠雽�於� 彀瀰鞚� 鞐嗞碃 齑濍秬毂勲姅 200毵� 雼煬(靸侂皹旮� 毵れ稖鞚� 0.9氚�)搿� 臧愳唽頃� 鞁犾毄 頃滊弰 雮挫棎 2540毵� 雼煬鞚� 臧�鞖╈劚鞚� 雮晞 鞛堨姷雼堧嫟. 鞖挫爠鞛愲掣鞚� 鞐爠頌� 2150毵� 雼煬搿� 鞏戫樃頃╇媹雼�.
欤检嫕 靾橂姅 2024雲� 鞛愲掣 頇曥订 鞚错泟 鞝勲厔 雽�牍� 30% 歃濌皜頃� 1850毵� 欤茧 欤茧嫻 歆�響滉皜 頋劃霅橃棃鞀惦媹雼�. 鞚挫棸靾橃澋鞚� 4% 歃濌皜頄堦碃 氙胳箔甑� 毂勱秾鞚� 26% 靸侅姽頃� 頃橂皹旮� 靾橃＜ 鞛旉碃 鞝勴櫂鞚� 鞁滌偓頃╇媹雼�. 瓴届榿歆勳潃 氇摖 PNC 瓿勳暯 臁瓣贝鞚� 於╈”頄堨溂氅�, 鞙犽彊靹膘澊 500毵� 雼煬毳� 齑堦臣頃� 霑� FCCR 韰岇姢韸鸽ゼ 鞕勴檾頃橂弰搿� 鞁犾毄 頃滊弰毳� 靾橃爼頄堨姷雼堧嫟.
欤检殧 鞖旍爯:
- 齑濎澊鞚惦 氚橃爠鞚� 旃橂 攵�氍胳潣 牍勳 歃濌皜鞕� 韽愱赴/頃橂弰旮� 牍勳毄 臧愳唽鞐� 旮办澑頃╇媹雼�.
- 順勱笀 靻岇 靻嶋弰臧� 鞕勴檾霅橁碃 鞛堨溂氅�, 鞛 靸來儨電� 瓴诫頃� 霠堧矂毽 靸來儨鞛呺媹雼�.
- 靹滊箘鞀� 攵�氍胳潣 鞎届劯鞕� 歃濌皜頃� 旮办梾 SG&A臧� 須岆车靹鸽ゼ 鞝滌暯頃╇媹雼�.
Le rapport 10-Q du deuxi猫me trimestre 2025 de PESI montre une nette am茅lioration op茅rationnelle, mais la rentabilit茅 reste difficile 脿 atteindre. Le chiffre d'affaires net a augment茅 de 4,3 % en glissement annuel pour atteindre 14,6 millions de dollars, port茅 par une hausse de 37 % des ventes dans le segment Traitement, qui a compens茅 une baisse de 43 % dans les Services. Le contr么le des co没ts a r茅duit le co没t des marchandises vendues (COGS) de 14,7 %, faisant passer la marge brute 脿 10,6 % contre -9,3 % l'ann茅e pr茅c茅dente ; cela a g茅n茅r茅 le premier b茅n茅fice brut trimestriel (1,5 million de dollars) depuis quatre trimestres. Les frais SG&A (en hausse de 19,5 % en glissement annuel) et la R&D ont maintenu l'entreprise dans le rouge, mais la perte d'exploitation s'est r茅duite 脿 2,9 millions (-43 %). La perte nette s'est am茅lior茅e 脿 2,7 millions (-0,15 $ par action) contre 4,0 millions (-0,27 $ par action).
Pour le premier semestre 2025, le chiffre d'affaires a augment茅 de 3,3 % pour atteindre 28,5 millions et le b茅n茅fice brut est devenu positif 脿 2,2 millions ; la perte nette a 茅t茅 r茅duite 脿 6,3 millions. La tr茅sorerie est tomb茅e 脿 22,6 millions contre 29,0 millions 脿 la fin 2024, les op茅rations ayant consomm茅 4,0 millions et les investissements 1,5 million. La liquidit茅 reste solide : aucun emprunt sur la ligne de cr茅dit renouvelable et la dette totale a diminu茅 脿 2,0 millions (0,9脳 les ventes du premier semestre), laissant 25,4 millions de disponibilit茅 sur la facilit茅 de cr茅dit. Le fonds de roulement reste positif 脿 21,5 millions.
Le nombre d'actions a augment茅 de 30 % en glissement annuel pour atteindre 18,5 millions suite aux lev茅es de fonds de 2024, diluant les indicateurs par action. Les revenus diff茅r茅s ont progress茅 de 4 % tandis que les cr茅ances non factur茅es ont augment茅 de 26 %, signalant une conversion du carnet de commandes au second semestre. La direction a respect茅 tous les seuils des covenants PNC et a modifi茅 la facilit茅 pour assouplir les tests FCCR lorsque la liquidit茅 d茅passe 5 millions.
Points cl茅s :
- L鈥檌nflexion de la marge brute est due 脿 une plus grande part du segment Traitement et 脿 des co没ts de mise au rebut/sous-traitance plus faibles.
- La consommation de tr茅sorerie ralentit ; le bilan est l茅g猫rement endett茅.
- La faiblesse du segment Services et la hausse des frais SG&A freinent la reprise.
Der 10-Q-Bericht von PESI f眉r das zweite Quartal 2025 zeigt eine deutliche operative Verbesserung, doch die Profitabilit盲t bleibt schwer erreichbar. Der Nettoumsatz stieg im Jahresvergleich um 4,3 % auf 14,6 Mio. USD, angetrieben durch einen 37%igen Anstieg der Ums盲tze im Behandlungssegment, der einen R眉ckgang im Servicebereich um 43 % ausglich. Durch Kostenkontrolle wurde der COGS um 14,7 % gesenkt, was die Bruttomarge von -9,3 % im Vorjahr auf 10,6 % anhob; dies f眉hrte zum ersten viertelj盲hrlichen Bruttogewinn (1,5 Mio. USD) seit vier Quartalen. SG&A (plus 19,5 % im Jahresvergleich) und F&E hielten das Unternehmen weiterhin in den roten Zahlen, jedoch verringerte sich der Betriebsverlust auf 2,9 Mio. USD (-43 %). Der Nettoverlust verbesserte sich auf 2,7 Mio. USD (-0,15 USD pro Aktie) gegen眉ber 4,0 Mio. USD (-0,27 USD pro Aktie).
F眉r das erste Halbjahr 2025 stiegen die Ums盲tze um 3,3 % auf 28,5 Mio. USD, und der Bruttogewinn wurde mit 2,2 Mio. USD positiv; der Nettoverlust verringerte sich auf 6,3 Mio. USD. Die liquiden Mittel fielen von 29,0 Mio. USD Ende 2024 auf 22,6 Mio. USD, da der operative Betrieb 4,0 Mio. USD und Investitionen 1,5 Mio. USD verbrauchten. Die Liquidit盲t bleibt solide 鈥� keine revolvierenden Kredite und die Gesamtschulden sanken auf 2,0 Mio. USD (0,9脳 Halbjahresumsatz), was eine Verf眉gbarkeit von 25,4 Mio. USD unter der Kreditfazilit盲t l盲sst. Das Working Capital ist mit 21,5 Mio. USD weiterhin positiv.
Die Anzahl der Aktien stieg nach Kapitalerh枚hungen 2024 um 30 % auf 18,5 Mio., was die Kennzahlen pro Aktie verw盲ssert. Die abgegrenzten Ertr盲ge stiegen um 4 %, w盲hrend nicht fakturierte Forderungen um 26 % zunahmen, was auf eine Umwandlung des Auftragsbestands in der zweiten Jahresh盲lfte hindeutet. Das Management erf眉llte alle PNC-Kovenanten und 盲nderte die Fazilit盲t, um FCCR-Tests zu lockern, wenn die Liquidit盲t 5 Mio. USD 眉bersteigt.
Wichtigste Erkenntnisse:
- Die Wende der Bruttomarge wurde durch einen h枚heren Anteil des Behandlungssegments und geringere Entsorgungs-/Subunternehmerkosten getrieben.
- Der Cash-Burn verlangsamt sich; die Bilanz ist leicht verschuldet.
- Die Schw盲che im Service-Segment und die gestiegenen SG&A-Kosten bremsen die Erholung.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Form
| QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For
the quarterly period ended
Or
| TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from ___________________to_________________
Commission
File No.
PERMA-FIX ENVIRONMENTAL SERVICES, INC.
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation or organization) |
(IRS
Employer | |
(Address of principal executive offices) |
(Zip Code) |
(Registrant’s telephone number)
| N/A |
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol | Name of each exchange on which registered | ||
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit and post such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
Large
accelerated filer ☐ Accelerated Filer ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial standards provided pursuant to Section 13(a) of the Exchange Act ☐
Indicate by check mark whether the registrant is a shell company
(as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No
Indicate the number of shares outstanding of each of the issuer’s classes of Common Stock, as of the close of the latest practical date.
| Class | Outstanding at August 4, 2025 | |
| Common
Stock, $ |
PERMA-FIX ENVIRONMENTAL SERVICES, INC.
INDEX
| Page No. | |||
| PART I | FINANCIAL INFORMATION | 1 | |
| Item 1. | Condensed Consolidated Financial Statements (Unaudited) | 1 | |
| Condensed Consolidated Balance Sheets - June 30, 2025 and December 31, 2024 | 1 | ||
| Condensed Consolidated Statements of Operations - Three and Six Months Ended June 30, 2025 and 2024 | 3 | ||
| Condensed Consolidated Statements of Comprehensive Loss - Three and Six Months Ended June 30, 2025 and 2024 | 4 | ||
| Condensed Consolidated Statements of Stockholders’ Equity - Six Months Ended June 30, 2025 and 2024 | 5 | ||
| Condensed Consolidated Statements of Cash Flows -Six Months Ended June 30, 2025 and 2024 | 6 | ||
| Notes to Condensed Consolidated Financial Statements | 7 | ||
| Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 23 | |
| Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 36 | |
| Item 4. | Controls and Procedures | 36 | |
| PART II | OTHER INFORMATION |
36 | |
| Item 1. | Legal Proceedings | 36 | |
| Item 1A. | Risk Factors | 36 | |
| Item 6. | Exhibits | 36 | |
PART I - FINANCIAL INFORMATION
Item 1. – Financial Statements
PERMA-FIX ENVIRONMENTAL SERVICES, INC.
Condensed Consolidated Balance Sheets
| 2025 | December 31, | |||||||
| June 30, | ||||||||
| 2025 | December 31, | |||||||
| (Amounts in Thousands, Except for Share and Per Share Amounts) | (Unaudited) | 2024 | ||||||
| ASSETS | ||||||||
| Current assets: | ||||||||
| Cash | $ | $ | ||||||
| Accounts receivable, net
of allowance for credit losses of $ | ||||||||
| Unbilled receivables | ||||||||
| Inventories | ||||||||
| Prepaid and other assets | ||||||||
| Current assets related to discontinued operations | ||||||||
| Total current assets | ||||||||
| Property and equipment: | ||||||||
| Buildings and land | ||||||||
| Equipment | ||||||||
| Vehicles | ||||||||
| Leasehold improvements | ||||||||
| Office furniture and equipment | ||||||||
| Construction-in-progress | ||||||||
| Total property and equipment | ||||||||
| Less accumulated depreciation | ( | ) | ( | ) | ||||
| Net property and equipment | ||||||||
| Property and equipment related to discontinued operations | ||||||||
| Operating lease right-of-use assets | ||||||||
| Intangibles and other long term assets: | ||||||||
| Permits | ||||||||
| Other intangible assets - net | ||||||||
| Finite risk sinking fund (restricted cash) | ||||||||
| Other assets | ||||||||
| Total assets | $ | $ | ||||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
| 1 |
PERMA-FIX ENVIRONMENTAL SERVICES, INC.
Condensed Consolidated Balance Sheets, Continued
| June 30, | ||||||||
| 2025 | December 31, | |||||||
| (Amounts in Thousands, Except for Share and per Share Amounts) | (Unaudited) | 2024 | ||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | $ | ||||||
| Accrued expenses | ||||||||
| Disposal/transportation accrual | ||||||||
| Deferred revenue | ||||||||
| Accrued closure costs - current | ||||||||
| Current portion of long-term debt | ||||||||
| Current portion of operating lease liabilities | ||||||||
| Current portion of finance lease liabilities | ||||||||
| Current liabilities related to discontinued operations | ||||||||
| Total current liabilities | ||||||||
| Accrued closure costs | ||||||||
| Long-term debt, less current portion | ||||||||
| Long-term operating lease liabilities, less current portion | ||||||||
| Long-term finance lease liabilities, less current portion | ||||||||
| Long-term liabilities related to discontinued operations | ||||||||
| Total long-term liabilities | ||||||||
| Total liabilities | ||||||||
| Commitments and Contingencies (Note 9) | - | - | ||||||
| Stockholders’ Equity: | ||||||||
| Preferred Stock, $ | — | — | ||||||
| Common Stock, $ | ||||||||
| Additional paid-in capital | ||||||||
| Accumulated deficit | ( | ) | ( | ) | ||||
| Accumulated other comprehensive loss | ( | ) | ( | ) | ||||
| Less
Common Stock in treasury, at cost; | ( | ) | ( | ) | ||||
| Total stockholders’ equity | ||||||||
| Total liabilities and stockholders’ equity | $ | $ | ||||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
| 2 |
PERMA-FIX ENVIRONMENTAL SERVICES, INC.
Condensed Consolidated Statements of Operations
(Unaudited)
| (Amounts in Thousands, Except for Per Share Amounts) | 2025 | 2024 | 2025 | 2024 | ||||||||||||
| Three Months Ended | Six Months Ended | |||||||||||||||
| June 30, | June 30, | |||||||||||||||
| (Amounts in Thousands, Except for Per Share Amounts) | 2025 | 2024 | 2025 | 2024 | ||||||||||||
| Net revenues | $ | $ | $ | $ | ||||||||||||
| Cost of goods sold | ||||||||||||||||
| Gross profit (loss) | ( | ) | ( | ) | ||||||||||||
| Selling, general and administrative expenses | ||||||||||||||||
| Research and development | ||||||||||||||||
| (Gain) loss on disposal of property and equipment | ( | ) | ( | ) | ||||||||||||
| Loss from operations | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Other income (expense): | ||||||||||||||||
| Interest income | ||||||||||||||||
| Interest expense | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Interest expense-financing fees | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Other | ||||||||||||||||
| Loss from continuing operations before taxes | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Income tax benefit | — | ( | ) | — | ( | ) | ||||||||||
| Loss from continuing operations, net of taxes | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Loss from discontinued operations, net of taxes (Note 10) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Net loss | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Net loss per common share - basic and diluted: | ||||||||||||||||
| Continuing operations | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Discontinued operations | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Net loss per common share | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Weighted average number of common shares used in computing net loss per share: | ||||||||||||||||
| Basic | ||||||||||||||||
| Diluted | ||||||||||||||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
| 3 |
PERMA-FIX ENVIRONMENTAL SERVICES, INC.
Condensed Consolidated Statements of Comprehensive Loss
(Unaudited)
| (Amounts in Thousands) | 2025 | 2024 | 2025 | 2024 | ||||||||||||
| Three Months Ended | Six Months Ended | |||||||||||||||
| June 30, | June 30, | |||||||||||||||
| (Amounts in Thousands) | 2025 | 2024 | 2025 | 2024 | ||||||||||||
| Net loss | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Other comprehensive income (loss): | ||||||||||||||||
| Foreign currency translation gain (loss) | ( | ) | ( | ) | ||||||||||||
| Total other comprehensive income (loss) | ( | ) | ( | ) | ||||||||||||
| Comprehensive loss | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
| 4 |
PERMA-FIX ENVIRONMENTAL SERVICES, INC
Condensed Consolidated Statement of Stockholders’ Equity
(Unaudited)
(Amounts in thousands, except for share amounts)
| Shares | Amount | Capital | In Treasury | Loss | Deficit | Equity | ||||||||||||||||||||||
| Common Stock | Additional Paid-In | Common Stock Held | Accumulated Other Comprehensive | Accumulated | Total Stockholders’ |
|||||||||||||||||||||||
| Shares | Amount | Capital | In Treasury | Loss | Deficit | Equity | ||||||||||||||||||||||
| Balance at December 31, 2024 | $ | $ | $ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ||||||||||||||||
| Net loss | — | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
| Foreign currency translation | — | — | — | — | — | |||||||||||||||||||||||
| Issuance of Common Stock for services | — | — | — | — | ||||||||||||||||||||||||
| Issuance of Common Stock upon exercise of options | — | — | — | — | ||||||||||||||||||||||||
| Stock-Based Compensation | — | — | — | — | — | |||||||||||||||||||||||
| Balance at March 31, 2025 | $ | $ | $ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ||||||||||||||||
| Net loss | — | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
| Foreign currency translation | — | — | — | — | — | |||||||||||||||||||||||
| Issuance of Common Stock for services | — | — | — | — | ||||||||||||||||||||||||
| Issuance of Common Stock upon exercise of options | — | — | — | — | ||||||||||||||||||||||||
| Stock-Based Compensation | — | — | — | — | — | |||||||||||||||||||||||
| Balance at June 30, 2025 | $ | $ | $ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ||||||||||||||||
| Balance at December 31, 2023 | $ | $ | $ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ||||||||||||||||
| Net loss | — | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
| Foreign currency translation | — | — | — | — | ( |
) | — | ( |
) | |||||||||||||||||||
| Issuance of Common Stock for services | — | — | — | — | ||||||||||||||||||||||||
| Issuance of Common Stock upon exercise of options | — | — | — | — | ||||||||||||||||||||||||
| Issuance of Common Stock upon exercise of warrant | — | — | — | — | ||||||||||||||||||||||||
| Stock-Based Compensation | — | — | — | — | — | |||||||||||||||||||||||
| Balance at March 31, 2024 | $ | $ | $ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ||||||||||||||||
| Balance | $ | $ | $ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ||||||||||||||||
| Net loss | — | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
| Foreign currency translation | — | — | — | — | ( |
) | — | ( |
) | |||||||||||||||||||
| Issuance of Common Stock for services | — | — | — | — | ||||||||||||||||||||||||
| Issuance of Common Stock upon exercise of options | — | — | — | — | ||||||||||||||||||||||||
| Sale of Common Stock, net of offering costs | — | — | — | |||||||||||||||||||||||||
| Issuance of warrants from sale of Common Stock | — | — | — | — | — | |||||||||||||||||||||||
| Stock-Based Compensation | — | — | — | — | — | |||||||||||||||||||||||
| Balance at June 30, 2024 | $ | $ | $ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ||||||||||||||||
| Balance | $ | $ | $ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ||||||||||||||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
| 5 |
PERMA-FIX ENVIRONMENTAL SERVICES, INC.
Condensed Consolidated Statements of Cash Flows
(Unaudited)
| (Amounts in Thousands) | 2025 | 2024 | ||||||
| Six Months Ended | ||||||||
| June 30, | ||||||||
| (Amounts in Thousands) | 2025 | 2024 | ||||||
| Cash flows from operating activities: | ||||||||
| Net loss | $ | ( | ) | $ | ( | ) | ||
| Less: loss from discontinued operations, net of taxes (Note 10) | ( | ) | ( | ) | ||||
| Loss from continuing operations, net of taxes | ( | ) | ( | ) | ||||
| Adjustments to reconcile loss from continuing operations to cash used in operating activities: | ||||||||
| Depreciation and amortization | ||||||||
| Amortization of debt issuance costs | ||||||||
| Deferred tax benefit | — | ( | ) | |||||
| Provision for (recovery of) credit losses on accounts receivable | ( | ) | ||||||
| (Gain) loss on disposal of property and equipment | ( | ) | ||||||
| Issuance of common stock for services | ||||||||
| Stock-based compensation | ||||||||
| Changes in operating assets and liabilities of continuing operations | ||||||||
| Accounts receivable | ||||||||
| Unbilled receivables | ( | ) | ||||||
| Prepaid expenses, inventories and other assets | ||||||||
| Accounts payable, accrued expenses and unearned revenue | ( | ) | ( | ) | ||||
| Cash used in continuing operations | ( | ) | ( | ) | ||||
| Cash used in discontinued operations | ( | ) | ( | ) | ||||
| Cash used in operating activities | ( | ) | ( | ) | ||||
| Cash flows from investing activities: | ||||||||
| Purchases of property and equipment, net of financed amount | ( | ) | ( | ) | ||||
| Additions to permits and other intangible assets | ( | ) | ( | ) | ||||
| Proceeds from sale of property and equipment | ||||||||
| Cash used in continuing operations | ( | ) | ( | ) | ||||
| Cash used in discontinued operations | ( | ) | ( | ) | ||||
| Cash used in investing activities | ( | ) | ( | ) | ||||
| Cash flows from financing activities: | ||||||||
| Repayments of revolving credit borrowings | ( | ) | ( | ) | ||||
| Borrowing on revolving credit | ||||||||
| Proceeds from issuance of Common Stock upon exercise of options/warrant | ||||||||
| Proceeds from sale of Common Stock completed in May 2024, net of offering costs paid | — | |||||||
| Payment of offering costs from sale of Common Stock completed in December 2024 | ( | ) | — | |||||
| Principal repayments of finance lease liabilities | ( | ) | ( | ) | ||||
| Principal repayments of long term debt | ( | ) | ( | ) | ||||
| Payment of debt issuance costs | ( | ) | ( | ) | ||||
| Cash (used in) provided by financing activities of continuing operations | ( | ) | ||||||
| Effect of exchange rate changes on cash | ( | ) | ||||||
| (Decrease) increase in cash and finite risk sinking fund (restricted cash) | ( | ) | ||||||
| Cash and finite risk sinking fund (restricted cash) at beginning of period | ||||||||
| Cash and finite risk sinking fund (restricted cash) at end of period | $ | $ | ||||||
| Supplemental disclosure: | ||||||||
| Interest paid | $ | $ | ||||||
| Income taxes paid | — | |||||||
| Non-cash financing activities: | ||||||||
| Equipment purchase subject to finance | — | |||||||
| Equipment purchase subject to finance leases | — | |||||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
| 6 |
PERMA-FIX ENVIRONMENTAL SERVICES, INC.
Notes to Condensed Consolidated Financial Statements
June 30, 2025
(Unaudited)
| 1. | Basis of Presentation |
The condensed consolidated financial statements included herein have been prepared by the Company (which may be referred to as we, us or our), without an audit, pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) have been condensed or omitted pursuant to such rules and regulations, although the Company believes the disclosures which are made are adequate to make the information presented not misleading. Further, the condensed consolidated financial statements reflect, in the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position and results of operations as of and for the periods indicated. The results of operations for the six months ended June 30, 2025, are not necessarily indicative of results to be expected for the fiscal year ending December 31, 2025.
These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K as of and for the year ended December 31, 2024.
The condensed consolidated financial statements include the accounts of our wholly-owned subsidiaries.
Immaterial Correction of an Error
The
Company reclassified $
| 2. | Summary of Significant Accounting Policies |
Our accounting policies are as set forth in the notes to the December 31, 2024, consolidated financial statements referred to above.
Recently Issued Accounting Standards –Adopted
In August 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-05, “Business Combinations—Joint Venture Formations (Subtopic 805-60): Recognition and Initial Measurement.” ASU 2023-05 applies to the formation of a “joint venture” or a “corporate joint venture” and requires a joint venture to initially measure all contributions received upon its formation at fair value. The guidance does not impact accounting by the venturers. The new guidance is applicable to joint venture entities with a formation date on or after January 1, 2025, on a prospective basis. The adoption of ASU 2023-05 by the Company on January 1, 2025, had no impact to its condensed consolidated financial statements.
Recently Issued Accounting Standards – Not Yet Adopted
In November 2024, the FASB issued ASU 2024-03, “Income Statement— Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40) - Disaggregation of Income Statement Expenses,” which enhances the disclosures required for certain expense captions in the Company’s annual and interim consolidated financial statements. ASU 2024-03 is effective prospectively or retrospectively for fiscal years beginning after December 15, 2026, and for interim periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of this standard on its disclosures.
| 7 |
In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures”, which modifies the rules on income tax disclosures to require entities to disclose (1) specific categories in the rate reconciliation, (2) the income or loss from continuing operations before income tax expense or benefit (separated between domestic and foreign) and (3) income tax expense or benefit from continuing operations (separated by federal, state and foreign). ASU 2023-09 also requires entities to disclose their income tax payments to international, federal, state and local jurisdictions, among other changes. ASU 2023-09 will become effective starting with the Company’s annual financial statements for the year ended December 31, 2025. The Company is currently evaluating the impact of this standard on its disclosures.
| 3. | Revenue |
Disaggregation of Revenue
In general, the Company’s business segmentation is aligned according to the nature and economic characteristics of our services and provides meaningful disaggregation of each business segment’s results of operations. The nature of the Company’s performance obligations within our Treatment and Services Segments results in the recognition of our revenue primarily over time. The following tables present further disaggregation of our revenues by different categories for our Services and Treatment Segments:
Schedule of Disaggregation of Revenue
| Treatment | Services | Total | Treatment | Services | Total | |||||||||||||||||||
| Revenue by Contract Type | ||||||||||||||||||||||||
| (In thousands) | Three Months Ended | Three Months Ended | ||||||||||||||||||||||
| June 30, 2025 | June 30, 2024 | |||||||||||||||||||||||
| Treatment | Services | Total | Treatment | Services | Total | |||||||||||||||||||
| Fixed price | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
| Time and materials | — | — | ||||||||||||||||||||||
| Total | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
| Treatment | Services | Total | Treatment | Services | Total | |||||||||||||||||||
| Revenue by Contract Type | ||||||||||||||||||||||||
| (In thousands) | Six Months Ended | Six Months Ended | ||||||||||||||||||||||
| June 30, 2025 | June 30, 2024 | |||||||||||||||||||||||
| Treatment | Services | Total | Treatment | Services | Total | |||||||||||||||||||
| Fixed price | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
| Time and materials | — | — | ||||||||||||||||||||||
| Total | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
| Treatment | Services | Total | Treatment | Services | Total | |||||||||||||||||||
| Revenue by generator | ||||||||||||||||||||||||
| (In thousands) | Three Months Ended | Three Months Ended | ||||||||||||||||||||||
| June 30, 2025 | June 30, 2024 | |||||||||||||||||||||||
| Treatment | Services | Total | Treatment | Services | Total | |||||||||||||||||||
| Domestic government | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
| Domestic commercial | ||||||||||||||||||||||||
| Foreign government | ||||||||||||||||||||||||
| Foreign commercial | ||||||||||||||||||||||||
| Total | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
| Treatment | Services | Total | Treatment | Services | Total | |||||||||||||||||||
| Revenue by generator | ||||||||||||||||||||||||
| (In thousands) | Six Months Ended | Six Months Ended | ||||||||||||||||||||||
| June 30, 2025 | June 30, 2024 | |||||||||||||||||||||||
| Treatment | Services | Total | Treatment | Services | Total | |||||||||||||||||||
| Domestic government | $ | $ | $ | $ | $ | |||||||||||||||||||
| Domestic commercial | ||||||||||||||||||||||||
| Foreign government | ||||||||||||||||||||||||
| Foreign commercial | ||||||||||||||||||||||||
| Total | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
| 8 |
Contract Balances
The timing of revenue recognition and billings can result in unbilled receivables (contract assets). The Company’s contract liabilities consist of deferred revenues which represent advance payment from customers in advance of the completion of the Company’s performance obligation. The following table represents changes in our contract asset and contract liabilities balances for the periods noted:
Schedule of Contract Balances
| Year-to-date | Year-to-date | |||||||||||||||
| (In thousands) | June 30, 2025 | December 31, 2024 | Change ($) | Change (%) | ||||||||||||
| Contract assets | ||||||||||||||||
| Unbilled receivables - current | $ | $ | $ | % | ||||||||||||
| Contract liabilities | ||||||||||||||||
| Deferred revenue | $ | $ | $ | % | ||||||||||||
| Year-to-date | Year-to-date | |||||||||||||||
| (In thousands) | June 30, 2024 | December 31, 2023 | Change ($) | Change (%) | ||||||||||||
| Contract assets | ||||||||||||||||
| Unbilled receivables - current | $ | $ | $ | ( | ) | - | % | |||||||||
| Contract liabilities | ||||||||||||||||
| Deferred revenue | $ | $ | $ | ( | ) | - | % | |||||||||
During
the three and six months ended June 30, 2025, the Company recognized revenue of $
Accounts Receivable
The following table represents changes in accounts receivable, net of credit losses, for the periods noted:
Schedule of Changes in Accounts Receivable, Net of Credit Losses
| Year-to-date | Year-to-date | |||||||||||||||
| (In thousands) | June 30, 2025 | December 31, 2024 | Change ($) | Change (%) | ||||||||||||
| Accounts Receivable (net) | $ | $ | $ | ( | ) | - | % | |||||||||
| Year-to-date | Year-to-date | |||||||||||||||
| June 30, 2024 | December 31, 2023 | Change ($) | Change (%) | |||||||||||||
| Accounts Receivable (net) | $ | $ | $ | ( | ) | - | % |
Remaining Performance Obligations
The Company applies the practical expedient in Accounting Standards Codification (“ASC”) 606-10-50-14 and does not disclose information about remaining performance obligations that have original expected durations of one year or less.
Within our Services Segment, there are service contracts which provide that the Company has a right to consideration from a customer in an amount that corresponds directly with the value to the customer of our performance completed to date. For those contracts, the Company has utilized the practical expedient in ASC 606-10-55-18, which allows the Company to recognize revenue in the amount for which we have the right to invoice; accordingly, the Company does not disclose the value of remaining performance obligations for those contracts.
The Company’s contracts and subcontracts relating to activities at governmental sites generally allow for termination for convenience at any time at the government’s option without payment of a substantial penalty. The Company does not disclose remaining performance obligations on these contracts.
| 9 |
| 4. | Leases |
At the inception of an arrangement, the Company determines if an arrangement is, or contains, a lease based on facts and circumstances present in that arrangement. Lease classifications, recognition, and measurement are then determined at the lease commencement date.
The Company’s operating lease right-of-use (“ROU”) assets and operating lease liabilities include primarily leases for office and warehouse spaces used to conduct our business. Finance leases primarily consist of lab, processing and transport equipment used by our facilities’ operations.
The components of lease cost for the Company’s leases for the three and six months ended June 30, 2025, and 2024 were as follows (in thousands):
Schedule of Components of Lease Cost
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Three Months Ended | Six Months Ended | |||||||||||||||
| June 30, | June 30, | |||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Operating Leases: | ||||||||||||||||
| Lease cost | $ | $ | $ | $ | ||||||||||||
| Finance Leases: | ||||||||||||||||
| Amortization of ROU assets | ||||||||||||||||
| Interest on lease liability | ||||||||||||||||
| Finance lease | ||||||||||||||||
| Short-term lease rent expense | ||||||||||||||||
| Total lease cost | $ | $ | $ | $ | ||||||||||||
The weighted average remaining lease term and the weighted average discount rate for operating and finance leases as of June 30, 2025, were:
Schedule of Weighted Average Lease
| Operating Leases | Finance Leases | |||||||
| Weighted average remaining lease terms (years) | ||||||||
| Weighted average discount rate | % | % | ||||||
The weighted average remaining lease term and the weighted average discount rate for operating and finance leases at June 30, 2024, were:
| Operating Leases | Finance Leases | |||||||
| Weighted average remaining lease terms (years) | ||||||||
| Weighted average discount rate | % | % | ||||||
| 10 |
The following table reconciles the undiscounted cash flows for the operating and finance leases as of June 30, 2025, to the operating and finance lease liabilities recorded on the balance sheet (in thousands):
Schedule of Operating and Finance Lease Liability Maturity
| Operating Leases | Finance Leases | |||||||
| 2025 (Remaining) | $ | $ | ||||||
| 2026 | ||||||||
| 2027 | ||||||||
| 2028 | ||||||||
| 2029 | ||||||||
| 2030 and thereafter | — | |||||||
| Total undiscounted lease payments | ||||||||
| Less: Imputed interest | ( | ) | ( | ) | ||||
| Present value of lease payments | $ | $ | ||||||
| Current portion of operating lease obligations | $ | $ | — | |||||
| Long-term operating lease obligations, less current portion | $ | $ | — | |||||
| Current portion of finance lease obligations | $ | — | $ | |||||
| Long-term finance lease obligations, less current portion | $ | — | $ | |||||
Supplemental cash flow and other information related to our leases were as follows for the three and six months ended June 30, 2025, and 2024 (in thousands):
Schedule of Supplemental Cash Flow and Other Information Related to Leases
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Three Months Ended | Six Months Ended | |||||||||||||||
| June 30, | June 30, | |||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Cash paid for amounts included in the measurement of lease liabilities: | ||||||||||||||||
| Operating cash flow used in operating leases | $ | $ | $ | $ | ||||||||||||
| Operating cash flow used in finance leases | $ | $ | $ | $ | ||||||||||||
| Financing cash flow used in finance leases | $ | $ | $ | $ | ||||||||||||
| ROU assets obtained in exchange for lease obligations for: | ||||||||||||||||
| Finance liabilities | $ | — | $ | — | $ | $ | — | |||||||||
| Operating liabilities | $ | — | $ | $ | — | $ | ||||||||||
| 5. | Intangible Assets |
The following table summarizes information relating to the Company’s definite-lived intangible assets:
Schedule of Definite Lived Intangible Assets
| June 30, 2025 | December 31, 2024 | |||||||||||||||||||||||||||
| Other Intangibles (amount in thousands) | Weighted Average Amortization Period (Years) | Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | Gross
Carrying Amount | Accumulated
Amortization | Net
Carrying Amount | |||||||||||||||||||||
| Patents | $ | $ | ( | ) | $ | $ | $ | ( | ) | $ | ||||||||||||||||||
| Software | ( | ) | ( | ) | ||||||||||||||||||||||||
| Total | $ | $ | ( | ) | $ | $ | $ | ( | ) | $ | ||||||||||||||||||
The intangible assets noted above are amortized on a straight-line basis over their useful lives.
The following table summarizes the expected amortization over the next five years for our definite-lived intangible assets:
Schedule of Finite Lived Intangible Assets, Future Amortization Expense
| Amount | ||||
| Year | (In thousands) | |||
| 2025 (Remaining) | $ | |||
| 2026 | ||||
| 2027 | ||||
| 2028 | ||||
| 2029 | ||||
| 11 |
Amortization
expenses relating to the definite-lived intangible assets as discussed above were $
| 6. | Capital Stock, Stock Plans, Warrants and Stock Based Compensation |
The Company has certain stock option plans under which it may award incentive stock options (“ISOs”) and/or non-qualified stock options (“NQSOs”) to employees, officers, outside directors, and outside consultants.
In
connection with the appointment of Mr. Troy Eshleman to the position of Chief Operating Officer (“COO”) by the Company’s
Board of Directors (the “Board”) on January 23, 2025, the Compensation and Stock Option Committee (the “Compensation
Committee”) recommended, and the Board approved, the grant to Mr. Eshleman of an ISO for the purchase, under the Company’s
2017 Stock Option Plan (the “2017 Plan”), of up to
The following table summarizes stock-based compensation recognized for the three and six months ended June 30, 2025, and 2024 for our employee and director stock options.
Schedule of Share-based Compensation, Allocation of Recognized Period Costs
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Three Months Ended | Six Months Ended | |||||||||||||||
| Stock Options | June 30, | June 30, | ||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Employee Stock Options | $ | $ | $ | $ | ||||||||||||
| Director Stock Options | ||||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||||
As
of June 30, 2025, the Company had approximately $
The summary of the Company’s total Stock Option Plans as of June 30, 2025, and June 30, 2024, and changes during the periods then ended, are presented below. The Company’s Plans consist of the 2017 Plan and the 2003 Outside Directors Stock Plan (the “2003 Plan”):
Schedule of Stock Options Roll Forward
| Shares | Weighted Average Exercise Price | Weighted Average Remaining Contractual Term (years) | Aggregate Intrinsic Value (5) | |||||||||||||
| Options outstanding January 1, 2025 | $ | - | ||||||||||||||
| Granted | $ | |||||||||||||||
| Exercised | ( | ) | $ | $ | ||||||||||||
| Forfeited | ( | ) | $ | |||||||||||||
| Options outstanding end of period (1) | $ | $ | ||||||||||||||
| Options exercisable at June 30, 2025(2) | $ | $ | ||||||||||||||
| 12 |
| Shares | Weighted Average Exercise Price | Weighted Average Remaining Contractual Term (years) | Aggregate Intrinsic Value (5) | |||||||||||||
| Options outstanding January 1, 2024 | $ | - | ||||||||||||||
| Granted | $ | |||||||||||||||
| Exercised | ( | ) | $ | $ | ||||||||||||
| Forfeited | ( | ) | $ | |||||||||||||
| Options outstanding end of period (3) | $ | $ | ||||||||||||||
| Options exercisable at June 30, 2024(4) | $ | $ | ||||||||||||||
| (1) | |
| (2) | |
| (3) | |
| (4) | |
| (5) |
During
the six months ended June 30, 2025, the Company issued a total of
During
the six months ended June 30, 2025, the Company issued an aggregate
In
connection with the Company’s sales of its Common Stock in May 2024 and December 2024, the Company issued warrants to certain underwriter,
placement agents and their designees to purchase up to an aggregate
| 13 |
| 7. | Loss Per Share |
Basic loss per share is calculated based on the weighted-average number of outstanding common shares during the applicable period. Diluted loss per share is based on the weighted-average number of outstanding common shares plus the weighted-average number of potential outstanding common shares. In periods where they are anti-dilutive, such amounts are excluded from the calculations of dilutive earnings per share. The following table reconciles the loss and average share amounts used to compute both basic and diluted loss per share:
Schedule of Earnings Per Share
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Three Months Ended | Six Months Ended | |||||||||||||||
| June 30, | June 30, | |||||||||||||||
| (Amounts in Thousands, Except for Per Share Amounts) | (Unaudited) | (Unaudited) | ||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Loss per common share from continuing operations | ||||||||||||||||
| Loss from continuing operations, net of taxes | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Basic loss per share | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Diluted loss per share | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Loss per common share from discontinued operations, net of taxes | ||||||||||||||||
| Loss from discontinued operations, net of taxes | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Basic loss per share | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Diluted loss per share | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Net loss per common share | ||||||||||||||||
| Net loss | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Basic loss per share | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Diluted loss per share | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Weighted average shares outstanding: | ||||||||||||||||
| Basic weighted average shares outstanding | ||||||||||||||||
| Add: dilutive effect of stock options | — | — | — | — | ||||||||||||
| Add: dilutive effect of warrants | — | — | — | — | ||||||||||||
| Diluted weighted average shares outstanding | ||||||||||||||||
For
the three and six months ended June 30, 2025,
For
the three and six months ended June 30, 2024,
| 8. | Long Term Debt |
Long-term debt consists of the following as of June 30, 2025, and December 31, 2024:
Schedule of Long Term Debt
| (Amounts in Thousands) | June
30, 2025 | December
31, 2024 | ||||||
| Revolving Credit facility dated May 8, 2020, borrowings based upon eligible accounts receivable, subject to monthly borrowing base calculation, balance due on May 15, 2027. Effective interest rates for first six months of 2025 was 9.5% (1) | $ | — | $ | — | ||||
| Revolving Credit facility
dated May 8, 2020, borrowings based upon eligible accounts receivable, subject to monthly borrowing base calculation, balance due
on | $ | — | $ | — | ||||
| Term Loan dated July 31,
2023, payable in equal monthly installments of principal, balance due on | ||||||||
| Capital Loan dated May 4, 2021, payable in equal
monthly installments of principal, balance due on | ||||||||
| Debt Issuance Costs (2) | ( | )(2) | ( | )(2) | ||||
| Notes
Payable up to 2044, with annual interest rates ranging from | ||||||||
| Total debt | ||||||||
| Less current portion of long-term debt | ||||||||
| Long-term debt | $ | $ | ||||||
| (1) |
| (2) |
| (3) |
| 14 |
Credit Facility
The
Company entered into a Second Amended and Restated Revolving Credit, Term Loan and Security Agreement, dated May 8, 2020, which has since
been amended, with PNC National Association (“PNC” and “lender”), acting as agent and lender (the “Loan
Agreement”). The Loan Agreement provides the Company with a credit facility with a maturity date of
On March 11, 2025, the Company entered into an amendment to its Loan Agreement with its lender which provided the following, among other things:
| ● | removed
the quarterly fixed charge coverage ratio (“FCCR”) covenant testing requirement
utilizing a twelve-month trailing basis; however, such FCCR testing requirement will be triggered
on the day the Company fails to meet a minimum of $ | |
| ● | ||
| ● | required
payment of an amendment fee of $ |
As
of June 30, 2025, the Company had no outstanding borrowing under its Revolving Credit and its Liquidity was approximately $
| 15 |
The Company’s Loan Agreement, as amended, with PNC contains certain financial covenant requirements, along with customary representations and warranties. A breach of any of these financial covenant requirements, unless waived by PNC, could result in a default under the Company’s Loan Agreement allowing its lender to immediately require the repayment of all outstanding debt under the Company’s Loan Agreement and terminate all commitments to extend further credit. The Company met all of its financial covenant requirements in the first and second quarters of 2025.
| 9. | Commitments and Contingencies |
Hazardous Waste
In connection with our waste management services, the Company processes hazardous, non-hazardous, low-level radioactive and mixed (containing both hazardous and low-level radioactive) waste, which we transport to our own, or other, facilities for destruction or disposal. As a result of disposing of hazardous substances, in the event any cleanup is required at the disposal site, the Company could be a potentially responsible party for the costs of the cleanup notwithstanding any absence of fault on our part.
Legal Matters
In the normal course of conducting our business, the Company may be involved in various litigation. The Company is not a party to any litigation or governmental proceeding which our management believes could result in any judgments or fines against us that would have a material adverse effect on our financial position, liquidity or results of future operations.
Tetra Tech EC, Inc. (“Tetra Tech”)
During July 2020, Tetra Tech EC, Inc. (“Tetra Tech”) filed a complaint in the U.S. District Court for the Northern District of California (the “Court”) against CH2M Hill, Inc. (“CH2M”) and four subcontractors of CH2M, including the Company (“Defendants”). The complaint alleges various claims, including a claim for negligence, negligent misrepresentation, equitable indemnification and related business claims against all Defendants related to alleged damages suffered by Tetra Tech in respect of certain draft reports prepared by Defendants at the request of the U.S. Navy as part of an investigation and review of certain whistleblower complaints about Tetra Tech’s environmental restoration at the Hunter’s Point Naval Shipyard in San Francisco.
CH2M was hired by the Navy in 2016 to review Tetra Tech’s work. CH2M subcontracted with environmental consulting and cleanup firms Battelle Memorial Institute, Cabrera Services, Inc., SC&A, Inc. and the Company to assist with the review, according to the complaint.
The
Company’s insurance carrier provided a defense on our behalf in connection with this lawsuit, subject to a $
The majority of Tetra Tech’s claims were previously dismissed by the Court. The remaining claims of intentional interference with contractual relations and inducing a breach of contract were dismissed by the Court pursuant to Defendants’ request for summary judgment. Tetra Tech appealed the dismissal of the remaining two claims and subsequently agreed to withdraw its appeal, which the Court dismissed at Tetra Tech’s request. The litigation was resolved as of March 31, 2025, and Tetra Tech released and forever discharged the Company from any and all claims arising out of or in any way related to the complaint.
Michael O’Neill
On November 25, 2024, purported shareholder Michael O’Neill filed a complaint in the Court of Chancery of the State of Delaware against the Company and all current directors of the Company, asserting individual and class action claims for alleged breach of contract and breach of fiduciary duty. The case is styled Michael O’Neill v. Perma-Fix Environmental Services, Inc., et al., C.A. No. 2024-1211-PAF.
| 16 |
The
complaint purports to be brought by the named plaintiff individually and on behalf of all “similarly situated Perma-Fix stockholders.”
According to the complaint, defendants allegedly made materially false and misleading statements in its proxy statement filed with the
Securities and Exchange Commission on June 8, 2023 regarding the effect of broker non-votes. In particular, the complaint alleges that
defendants incorrectly stated in the proxy statement that broker non-votes would have no effect on the vote solicited to approve an amendment
to the Company’s 2017 Stock Option Plan to increase by
The Company believes that the complaint is without merit. The Company and the individual defendants are vigorously defending against the complaint.
The
Company’s insurance carrier is providing a defense in connection with this lawsuit, subject to a $
Shareholder Demand Letter
The Company’s Board received a demand letter, dated February 4, 2025 (the “Letter”), from a putative shareholder of the Company, claiming that a provision in the Company’s Amended and Restated Bylaws (“Bylaws”), requiring shareholders, to the fullest extent permitted by law, to indemnify the Company for attorneys’ fees in certain corporate proceedings in which the shareholder is not the prevailing party, must be removed. This provision of the Company’s Bylaws was adopted in 2012 when the Company adopted its Amended and Restated Bylaws. The statute prohibiting certain reimbursements of attorneys’ fees was adopted in 2015. The Letter demands that the Board amend its Bylaws to remove the particular provision in question.
After reviewing the Letter, the Board established a Demand Review Committee (the “Committee”) to review, analyze and evaluate the shareholder demand received above, and to make recommendations to the Board with respect to such demand. The Committee was ad hoc, in that the composition of the Committee will necessarily change in response to the specific shareholder demand. Initial members of the Committee are comprised of Board members who were not members of the Board in 2012 when the Company adopted its Bylaws and are disinterested and independent with respect to the matters set forth in the Letter discussed above. The Committee was authorized to engage, at the Company’s expense, experts and advisors that the Committee deems appropriate to assist in its review and determination. Based on the Committee’s review and analysis of the demand and the current case law, in connection with the above Letter, the Committee recommended to the Board to reject such demand as being baseless. Based on the Committee’s recommendation to the Board, the Board determined that the demand is meritless and rejected such demand.
Insurance
The
Company has a
| 17 |
Letter of Credits and Bonding Requirements
From
time to time, the Company is required to post standby letters of credit and various bonds to support contractual obligations to customers
and other obligations, including facility closures. As of June 30, 2025, the total amount of standby letters of credit outstanding was
approximately $
| 10. | Discontinued Operations |
The Company’s discontinued operations consist of all our subsidiaries included in our previous Industrial Segment which encompasses subsidiaries divested in 2011 and prior and three previously closed locations.
The
Company’s discontinued operations had net losses of $
The following table presents the major class of assets of discontinued operations as of June 30, 2025, and December 31, 2024. No assets and liabilities were held for sale at each of the periods noted.
Schedule of Disposal Groups, Including Discontinued Operation Balance Sheet
| June 30, | December 31, | |||||||
| (Amounts in Thousands) | 2025 | 2024 | ||||||
| Current assets | ||||||||
| Other assets | $ | $ | ||||||
| Total current assets | ||||||||
| Long-term assets | ||||||||
| Property, plant and equipment, net (1) | ||||||||
| Total long-term assets | ||||||||
| Total assets | $ | $ | ||||||
| Current liabilities | ||||||||
| Accounts payable | $ | $ | ||||||
| Accrued expenses and other liabilities | ||||||||
| Environmental liabilities | — | |||||||
| Total current liabilities | ||||||||
| Long-term liabilities | ||||||||
| Closure liabilities | ||||||||
| Environmental liabilities | ||||||||
| Total long-term liabilities | ||||||||
| Total liabilities | $ | $ | ||||||
| (1) |
| 11. | Operating Segments |
In accordance with ASC 280, “Segment Reporting”, the Company defines an operating segment as a business activity: (1) from which we may earn revenue and incur expenses; (2) whose operating results are regularly reviewed by the Chief Operating Decision Maker (“CODM”) to make decisions about resources to be allocated to the segment and assess its performance; and (3) for which discrete financial information is available.
| 18 |
The Company has two reporting segments, consisting of the Treatment and Services Segments, which are primarily based on a service offering approach and defined as follow:
TREATMENT SEGMENT, which includes:
| - | nuclear, low-level radioactive, mixed waste (containing both hazardous and low-level radioactive constituents), hazardous and non-hazardous waste treatment, processing and disposal services primarily through four uniquely licensed and permitted treatment and storage facilities; and | |
| - | R&D activities to identify, develop and implement innovative waste processing techniques for problematic waste streams. |
SERVICES SEGMENT, which includes:
| - | Technical services, which include: |
| ○ | professional radiological measurement and site survey of large government and commercial installations using advanced methods, technology and engineering; | |
| ○ | integrated Occupational Safety and Health services including industrial hygiene (“IH”) assessments; hazardous materials surveys, e.g., exposure monitoring; lead and asbestos management/abatement oversight; indoor air quality evaluations; health risk and exposure assessments; health & safety plan/program development, compliance auditing and training services; and Occupational Safety and Health Administration (“OSHA”) citation assistance; | |
| ○ | global technical services providing consulting, engineering, project management, waste management, environmental, and decontamination and decommissioning (“D&D”) field, technical, and management personnel and services to commercial and government customers; and | |
| ○ | on-site waste management services to commercial and governmental customers. |
| - | Nuclear services, which include: |
| ○ | technology-based services including engineering, D&D, specialty services and construction, logistics, transportation, processing and disposal; | |
| ○ | remediation of nuclear licensed and federal facilities and the remediation cleanup of nuclear legacy sites. Such services capability includes: project investigation; radiological engineering; partial and total plant D&D; facility decontamination, dismantling, demolition, and planning; site restoration; logistics; transportation; and emergency response; and |
| - | A company owned equipment calibration and maintenance laboratory that services, maintains, calibrates, and sources (i.e., rental) health physics, IH and customized nuclear, environmental, and occupational safety and health (“NEOSH”) instrumentation. |
The Company’s reporting segments exclude our corporate headquarter which serves to support its two reporting segments through various functions, such as our executives, finance, treasury, human resources, accounting, and legal departments. Financial results for the corporate headquarter are not considered by the CODM in evaluating the performance of the reportable segments. Our reporting segment also excludes our discontinued operations (see “Note 10 – Discontinued Operations”) which do not generate revenues.
The Company’s CODM is represented by its chief executive officer and chief operating officer (or “CODM group”). The CODM group evaluates the performance of the Treatment and Services segments and allocates resources (including financial or capital resources) to each reporting segment based on revenue and (loss) income from operations by comparing actual results for these metrics to budgeted and forecasted amounts for these metrics on a monthly, quarterly and year-to-date basis. The Company’s CODM group does not evaluate and allocate resources for the reportable segments using assets; therefore, the Company does not disclose assets for its reporting segments.
The table below summarizes loss from operations for the Company’s two reporting segments and its corporate headquarter and provides reconciliation of such financial metric to the Company’s consolidated totals for the three and six months ended June 30, 2025, and 2024 for our continuing operations. Significant segment expenses that are included in the measure of segment profit or losses for each reportable segment and regularly provided to the CODM group include payroll and benefit, material and supplies, disposal, transportation and subcontract expenses and are reflected separately, where applicable (in thousands).
| 19 |
Schedule of Segment Reporting Information
Segment Reporting for the Three Months Ended June 30, 2025
| Treatment | Services | Segments Total | Corporate (1) | Consolidated Total | ||||||||||||||||
| Revenue from external customers | $ | $ | $ | $ | — | $ | ||||||||||||||
| Cost of Goods Sold: | ||||||||||||||||||||
| Payroll and benefits expenses | — | |||||||||||||||||||
| Material and supplies expenses | — | — | ||||||||||||||||||
| Disposal expenses | — | — | ||||||||||||||||||
| Transportation expenses | — | — | ||||||||||||||||||
| Subcontract expenses | — | — | ||||||||||||||||||
| Other cost of goods sold (2) | — | |||||||||||||||||||
| Total cost of goods sold | — | |||||||||||||||||||
| Gross profit (loss) | ( | ) | — | |||||||||||||||||
| Selling, general and administrative expenses (“SG&A”): | ||||||||||||||||||||
| Payroll and benefits | ||||||||||||||||||||
| Other SG&A (3) | ||||||||||||||||||||
| Total SG&A | ||||||||||||||||||||
| Research and development | ||||||||||||||||||||
| Gain on disposal of property and equipment | ( | ) | — | ( | ) | — | ( | ) | ||||||||||||
| Loss from operations | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ( | ) | ||||||
| Interest income | ||||||||||||||||||||
| Interest expense | ( | ) | ||||||||||||||||||
| Interest expense-financing fees | ( | ) | ||||||||||||||||||
| Other income | ||||||||||||||||||||
| Loss from continuing operations before taxes | ( | ) | ||||||||||||||||||
| Income tax expense | — | |||||||||||||||||||
| Loss from continuing operations, net of taxes | $ | ( | ) | |||||||||||||||||
Segment Reporting for the Three Months Ended June 30, 2024
| Treatment | Services | Segments Total | Corporate (1) | Consolidated Total | ||||||||||||||||
| Revenue from external customers | $ | $ | $ | $ | — | $ | ||||||||||||||
| Cost of goods sold: | ||||||||||||||||||||
| Payroll and benefit expenses | — | |||||||||||||||||||
| Material and supplies expenses | — | — | ||||||||||||||||||
| Disposal expenses | — | — | ||||||||||||||||||
| Transportation expenses | — | — | ||||||||||||||||||
| Subcontract expenses | — | — | ||||||||||||||||||
| Other cost of goods sold (2) | — | |||||||||||||||||||
| Total cost of goods sold | — | |||||||||||||||||||
| Gross loss | ( | ) | ( | ) | ( | ) | — | ( | ) | |||||||||||
| SG&A: | ||||||||||||||||||||
| Payroll and benefits | ||||||||||||||||||||
| Other SG&A (3) | ||||||||||||||||||||
| Total SG&A | ||||||||||||||||||||
| Research and development | ||||||||||||||||||||
| Loss on disposal of property and equiment | — | — | ||||||||||||||||||
| Loss from operations | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ( | ) | ||||||
| Interest income | ||||||||||||||||||||
| Interest expense | ( | ) | ||||||||||||||||||
| Interest expense-financing fees | ( | ) | ||||||||||||||||||
| Other income | ||||||||||||||||||||
| Loss from continuing operations before taxes | ( | ) | ||||||||||||||||||
| Income tax benefit | ( | ) | ||||||||||||||||||
| Loss from continuing operations, net of taxes | $ | ( | ) | |||||||||||||||||
| 20 |
Segment Reporting for the Six Months Ended June 30, 2025
| Treatment | Services | Segments Total | Corporate(1) | Consolidated Total | ||||||||||||||||
| Revenue from external customers | $ | $ | $ | $ | — | $ | ||||||||||||||
| Cost of Goods Sold: | ||||||||||||||||||||
| Payroll and benefits expenses | — | |||||||||||||||||||
| Material and supplies expenses | — | — | ||||||||||||||||||
| Disposal expenses | — | — | ||||||||||||||||||
| Transportation expenses | — | — | ||||||||||||||||||
| Subcontract expenses | — | — | ||||||||||||||||||
| Other cost of goods sold (2) | — | |||||||||||||||||||
| Total cost of goods sold | — | |||||||||||||||||||
| Gross profit | — | |||||||||||||||||||
| SG&A: | ||||||||||||||||||||
| Payroll and benefits | ||||||||||||||||||||
| Other SG&A (3) | ||||||||||||||||||||
| Total SG&A | ||||||||||||||||||||
| Research and development | ||||||||||||||||||||
| Gain on disposal of property and equipment | ( | ) | ( | ) | ( | ) | — | ( | ) | |||||||||||
| Loss from operations | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ( | ) | ||||||
| Interest income | ||||||||||||||||||||
| Interest expense | ( | ) | ||||||||||||||||||
| Interest expense-financing fees | ( | ) | ||||||||||||||||||
| Other income | ||||||||||||||||||||
| Loss from continuing operations before taxes | ( | ) | ||||||||||||||||||
| Income tax expense | — | |||||||||||||||||||
| Loss from continuing operations, net of taxes | $ | ( | ) | |||||||||||||||||
Segment Reporting for the Six Months Ended June 30, 2024
| Treatment | Services | Segments Total | Corporate(1) | Consolidated Total | ||||||||||||||||
| Revenue from external customers | $ | $ | $ | $ | — | $ | ||||||||||||||
| Cost of goods sold: | ||||||||||||||||||||
| Payroll and benefit expenses | — | |||||||||||||||||||
| Material and supplies expenses | — | — | ||||||||||||||||||
| Disposal expenses | — | — | ||||||||||||||||||
| Transportation expenses | — | — | ||||||||||||||||||
| Subcontract expenses | — | — | ||||||||||||||||||
| Other cost of goods sold (2) | — | |||||||||||||||||||
| Total cost of goods sold | — | |||||||||||||||||||
| Gross loss | ( | ) | ( | ) | ( | ) | — | ( | ) | |||||||||||
| SG&A: | ||||||||||||||||||||
| Payroll and benefits | ||||||||||||||||||||
| Other SG&A (3) | ||||||||||||||||||||
| Total SG&A | ||||||||||||||||||||
| Research and development | ||||||||||||||||||||
| Loss on disposal of property and equiment | — | — | ||||||||||||||||||
| Loss from operations | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ( | ) | ||||||
| Interest income | ||||||||||||||||||||
| Interest expense | ( | ) | ||||||||||||||||||
| Interest expense-financing fees | ( | ) | ||||||||||||||||||
| Other income | ||||||||||||||||||||
| Loss from continuing operations before taxes | ( | ) | ||||||||||||||||||
| Income tax benefit | ( | ) | ||||||||||||||||||
| Loss from continuing operations, net of taxes | $ | ( | ) | |||||||||||||||||
| (1) | |
| (2) | Treatment - lab, regulatory, repair and maintenance, depreciation and amortization, travel, outside services and general expenses. Services - material and supplies, disposal, transportation, lab, regulatory, repair and maintenance, depreciation and amortization, travel, outside services and general expenses. |
| (3) | |
| Treatment-depreciation and amortization, travel, outside services, repair and maintenance and general expenses. | |
| Services- travel, outside services, repair and maintenance and general expenses. | |
| Corporate-repair and maintenance, depreciation and amortization, travel, public company, outside services and general expenses. |
| 21 |
The following table presents depreciation and amortization for the three and six months ended June 30, (in thousand):
Schedule of Depreciation and Amortization
| Three Months Ended | Six Months Ended | |||||||||||||||
| June 30, | June 30, | |||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Treatment | $ | $ | $ | $ | ||||||||||||
| Services | ||||||||||||||||
| Total segment | ||||||||||||||||
| Corporate | ||||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||||
| Depreciation and amortization | $ | $ | $ | $ | ||||||||||||
The following table presents capital expenditures for the three and six months ended June 30, (in thousand):
Schedule of Capital Expenditures
| Three Months Ended | Six Months Ended | |||||||||||||||
| June 30, | June 30, | |||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Treatment | $ | $ | $ | $ | ||||||||||||
| Services | ||||||||||||||||
| Total segment | ||||||||||||||||
| Corporate | — | — | — | — | ||||||||||||
| Total | $ | (1) | $ | (2) | $ | (1) | $ | (2) | ||||||||
| Capital expenditures | $ | (1) | $ | (2) | $ | (1) | $ | (2) | ||||||||
| (1) |
| (2) |
12. Income Taxes
The Company uses an estimated annual effective tax rate, which is based on expected annual income, statutory tax rates and tax planning opportunities available in the various jurisdictions in which the Company operates, to determine its quarterly provision for income taxes.
The
Company had income tax expense of $0 and income tax benefit of $
| 22 |
13. Subsequent Events
Management evaluated events occurring subsequent to June 30, 2025, through August 7, 2025, the date these condensed consolidated financial statements were available for issuance, and other than as noted below determined that no material recognizable subsequent events occurred.
Tax Matter
On July 4, 2025, the United States enacted tax reform legislation through the “One Big Beautiful Bill Act,” which changes existing U.S. tax laws, including extending or making permanent certain provisions of the Tax Cuts and Jobs Act, repealing certain clean energy initiatives, in addition to other changes. The Company continues to evaluate the impact the new legislation will have on its consolidated financial statements but does not anticipate a significant impact due to the Company’s valuation allowance position, among other things.
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Forward-looking Statements
Certain statements contained within this report may be deemed “forward-looking statements” within the meaning of the “Private Securities Litigation Reform Act of 1995.” All statements in this report other than a statement of historical fact are forward-looking statements that are subject to known and unknown risks, uncertainties, and other factors, which could cause actual results and performance of the Company to differ materially from such statements. The words “believe,” “expect,” “anticipate,” “intend,” “will,” and similar expressions identify forward-looking statements. Forward-looking statements contained herein relate to, among other things,
| ● | demand for our services; | |
| ● | effect of improvements to production in revenue; | |
| ● | reductions in the level of government funding; | |
| ● | impact of “One Big Beautiful Bill Act”; | |
| ● | effect of changes to leadership at DOE; | |
| ● | continued improvement in financial results the second half of 2025; | |
| ● | revenue contribution from the West Valley Development Project in the second half of 2025; | |
| ● | approvals of scope attributable to the Company under the West Valley Development Project contract; | |
| ● | sustained receipts from DOE’s Hanford facility; | |
| ● | operations of the West Valley Development Project; | |
| ● | Direct-Feed Low-Activity Waste (“DFLAW”) to begin operations in the fourth quarter of 2025; | |
| ● | reducing operating costs and non-essential expenditures; | |
| ● | ability to meet loan agreement financial covenant requirements; | |
| ● | spending priorities under new Administration; | |
| ● | stabilization in changes in new administration and supporting policies; | |
| ● | cash flow requirements for the next twelve months; | |
| ● | sufficient cash flow and Liquidity to fund operations for the next twelve months; | |
| ● | reduction in Liquidity; | |
| ● | international initiatives; | |
| ● | amount of capital expenditures; | |
| ● | manner in which the applicable government will be required to spend funding to remediate various sites; | |
| ● | expansion into international market; | |
| ● | funding of operating and capital expenditures from cash from operations, Liquidity under our Loan Agreement, and/or financing; | |
| ● | our PFAS (Per- and polyfluoroalkyl) technology process will exceed current treatment options available; | |
| ● | receipt of an additional 50,000 gallons of aqueous film-forming foam (“AFFF”) liquid; | |
| ● | deployment of the second generation unit; | |
| ● | strategy for our System; | |
| ● | advancement of our PFAS technology; | |
| ● | funding of remediation expenditures for sites from funds generated internally; | |
| ● | compliance with environmental regulations; | |
| ● | potential effect of being a potentially responsible party (“PRP”); and | |
| ● | potential violations of environmental laws and attendant remediation at our facilities. |
| 23 |
While the Company believes the expectations reflected in such forward-looking statements are reasonable, it can give no assurance such expectations will prove to be correct. There are a variety of factors which could cause future outcomes to differ materially from those described in this report, including, but not limited to:
| ● | general economic conditions and uncertainties; |
| ● | inability to properly bid contracts; |
| ● | reduction in or inability to obtain new contracts with federal, state and local governments, agencies and departments, resulting in a reduction in revenue; |
| ● | changes in federal government budgeting and spending priorities; |
| ● | failure by Congress or other governmental bodies to approve budgets and debt ceiling increases in a timely fashion and related reductions in government spending; |
| ● | uncertainties relating to the new presidential administration (the “Administration”) and failure of the Administration to spend Congressionally mandated appropriations, which may result in the failure to realize the full amount of our backlog; |
| ● | tariff actions and uncertainties related to trade wars; |
| ● | inability to meet PNC covenant requirements; |
| ● | inability to collect in a timely manner a material amount of receivables; |
| ● | increased competitive pressures; |
| ● | inability to maintain and obtain required permits and approvals to conduct operations; |
| ● | inability to develop new and existing technologies in the conduct of operations; |
| ● | inability to maintain and obtain closure and operating insurance requirements; |
| ● | discovery of additional contamination or expanded contamination at any of the sites or facilities leased or owned by us or our subsidiaries which would result in a material increase in remediation expenditures; |
| ● | refusal of third-party disposal sites to accept our waste; |
| ● | changes in federal, state and local laws and regulations, especially environmental laws and regulations, or in interpretation of such; |
| ● | new or additional requirements to handle low-level radioactive and hazardous waste materials; |
| ● | management retention and development; |
| ● | financial valuation of intangible assets is substantially more/less than expected; |
| ● | the need to use internally generated funds for purposes not presently anticipated; |
| ● | inability of the Company to maintain the listing of its Common Stock on the Nasdaq; |
| ● | terminations of contracts with government agencies or subcontracts involving government agencies or reduction in amount of waste delivered to the Company under the contracts or subcontracts; |
| ● | failure of our Italian team partner to perform its requirements in connection with the Italian project; |
| ● | changes in the scope of work relating to existing contracts; |
| ● | occurrence of an event similar to COVID-19 having adverse effects on the U.S. and world economics; |
| ● | renegotiation or termination of contracts involving government agencies; |
| ● | disposal expense accrual could prove to be inadequate in the event the waste requires re-treatment; |
| ● | inability to raise capital on commercially reasonable terms; |
| ● | inability to increase profitable revenue; |
| ● | risks resulting from expanding our service offerings and client base; |
| ● | non-acceptance of our new technology; |
| ● | adjustments to our valuation allowance; |
| ● | supply chain difficulties; |
| ● | pricing adjustments; |
| ● | cost reduction measures; |
| ● | new governmental regulations; and |
| ● | risk factors and other factors set forth in “Special Note Regarding Forward-Looking Statements” contained in the Company’s 2024 Form 10-K and the “Forward-Looking Statements” contained in the Management’s Discussion and Analysis of Financial Condition and Results of Operations” (“MD&A”) of the first quarter of 2025 and this second quarter 2025 10-Q. |
| 24 |
Our forward-looking statements are based on the beliefs and assumptions of our management and the information available to our management at the time these statements were prepared. Although we believe the expectations reflected in these statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. You should not place undue reliance on the forward-looking statements as noted above, which apply only to as of the date of this Form 10-Q. We undertake no obligation to update these forward-looking statements, even if our situation changes in the future.
Overview
Our results of operations for the second quarter of 2025 reflect marginal improvements from the corresponding period of 2024. Overall revenue increased by $600,000 or 4.3% to $14,586,000 for the three months ended June 30, 2025, from $13,986,000 in the same period of 2024. The increase was entirely from our Treatment Segment where revenue increased by $3,054,000 or approximately 36.6% to $11,397,000 for the three months ended June 30, 2025, from $8,343,000 in the same period of 2024. The increase in Treatment Segment revenue was primarily due to increased waste volume and higher averaged price waste from waste mix. With the increase in waste receipts within our Treatment Segment, production challenges were realized that adversely impacted revenue; however, we believe that these issues have been resolved through automation and operational adjustments. Services Segment revenue decreased $2,454,000 or 43.5% to $3,189,000 for the three months ended June 30, 2025, from $5,643,000 for the same period of 2024. The decrease was attributed in part, to delays in project mobilizations from existing contracts along with delays in procurements resulting from changes to the new Administration and supporting policies that continued into the second quarter of 2025. We anticipate these changes should stabilize in the near future as new leadership within the U.S. Department of Energy (“DOE”) and other primary federal clients nominate and confirm leadership into each agency. Gross profit increased $2,853,000 or 218.5% for the three months ended June 30, 2025, as compared to the corresponding period of 2024. Selling, General, and Administrative (“SG&A”) expenses increased by $675,000 or 19.5% for the three months ended June 30, 2025, as compared to the corresponding period of 2024.
Our overall revenue increased by $902,000 or 3.3% to $28,505,000 for the six months ended June 30, 2025, from $27,603,000 for the corresponding period of 2024. Similar to the second quarter of 2025, the increase was entirely from our Treatment Segment where revenue increased by $3,531,000 or approximately 20.7% to $20,583,000 for the six months ended June 30, 2025, from $17,052,000 in the same period of 2024. The increase in Treatment Segment revenue was primarily due to increased waste volume and higher averaged price waste from waste mix. Services Segment revenue decreased $2,629,000 or 24.9% to $7,922,000 for the six months ended June 30, 2025, from $10,551,000 for the same period of 2024 primarily due to the same reasons as discussed above for the three months ended June 30, 2025. We generated a gross profit of $2,204,000 for the six months ended June 30, 2025, as compared to a gross loss of $1,926,000 for the corresponding period of 2024, reflecting an overall increase in gross profit of $4,130,000 or 214.4%. SG&A expenses increased by $1,146,000 or 16.4% for the six months ended June 30, 2025, as compared to the corresponding period of 2024.
See below “Results of Operations” for further discussions of our financial results for the three and six months ended June 30, 2025 as compared to the corresponding period of 2024.
| 25 |
Although we saw marginal improvements in our financial results in the second quarter of 2025 and the six months ended June 30, 2025, as compared to the corresponding periods of 2024, our results of operations for these periods did not meet our expectation. However, we believe we are well positioned for continued improvements in the second half of 2025. Our Treatment backlog stands at approximately $13,151,000, an increase of $5,292,000 or 67.3% from the December 31, 2024, balance of $7,859,000. Additionally, in December 2024, BWXT Technologies and its team, of which we are a member, were awarded the West Valley Project contract for the cleanup operations at the West Valley Development Project in West Valley, New York. The contract has a 10-year ordering period with a maximum value of up to $3 billion that can be performed for up to 15 years. We expect revenue contribution from this project in the second half of 2025 as our scope under the contract is further defined, approved and transitions into operation. Also, we expect that the DFLAW program at Hanford, Washington will begin initial tank waste treatment operations in the fourth quarter of 2025 which we believe our PFNWR facility is well-positioned to support. We continue to focus on increasing our expansion into the international markets which is reflected in revenue generated from foreign entities of approximately $3,589,000 for the six months ended June 30, 2025, as compared to $1,030,000 for the corresponding period of 2024, an increase of $2,559,000 or 248.4%. Finally, we continue our aggressive approach in research and development (“R&D”), sales and marketing efforts and capital expenditures of our new PFAS technology which adversely impacted our results of operations for the first six months of 2025 (See “Known Trends and Uncertainties – New Processing Technology” for a discussion of our new technology).
We are attempting to make strategic improvements to our plants and equipment and bolster our operational staff to maximize our revenue production capabilities. We are continually monitoring our operating costs to ensure alignment with our revenue level.
See “Federal Funding” and “Market Trends and Uncertainties” in “Known Trends and Uncertainties” within this MD&A for a discussion of factors that could negatively impact our results of operations for the remainder of 2025.
Business Environment
Our Treatment and Services Segments’ business continues to be heavily dependent on services that we provide to federal governmental clients, primarily as subcontractors for others who are contractors to government entities or directly as the prime contractor. We believe demand for our services will continue to be subject to fluctuations due to a variety of factors beyond our control, including, without limitation, current economic and political conditions, government reductions, COVID like events, government budget issues and the manner in which the applicable government authority will be required to spend funding to remediate various sites. In addition, our governmental contracts and subcontracts relating to activities at federal governmental sites are generally subject to termination for convenience at any time, at the government’s option. Significant reductions in the level of governmental funding or specifically mandated levels for different programs that are important to our business could have a material adverse impact on our business, financial position, results of operations, and cash flows.
Results of Operations
The reporting of financial results and pertinent discussions are tailored to our two reportable segments: The Treatment and Services.
| 26 |
Summary – Three and Six Months Ended June 30, 2025 and 2024
| Three Months Ended | Six Months Ended | |||||||||||||||||||||||||||||||
| June 30, | June 30, | |||||||||||||||||||||||||||||||
| Consolidated (amounts in thousands) | 2025 | % | 2024 | % | 2025 | % | 2024 | % | ||||||||||||||||||||||||
| Net revenues | $ | 14,586 | 100.0 | $ | 13,986 | 100.0 | $ | 28,505 | 100.0 | $ | 27,603 | 100.0 | ||||||||||||||||||||
| Cost of goods sold | 13,039 | 89.4 | 15,292 | 109.3 | 26,301 | 92.3 | 29,529 | 107.0 | ||||||||||||||||||||||||
| Gross profit (loss) | 1,547 | 10.6 | (1,306 | ) | (9.3 | ) | 2,204 | 7.7 | (1,926 | ) | (7.0 | ) | ||||||||||||||||||||
| Selling, general and administrative | 4,130 | 28.3 | 3,455 | 24.7 | 8,145 | 28.6 | 6,999 | 25.4 | ||||||||||||||||||||||||
| Research and development | 312 | 2.1 | 273 | 2.0 | 695 | 2.4 | 569 | 2.0 | ||||||||||||||||||||||||
| (Gain) loss on disposal of property and equipment | (1 | ) | — | 1 | — | (6 | ) | — | 1 | — | ||||||||||||||||||||||
| Loss from operations | (2,894 | ) | (19.8 | ) | (5,035 | ) | (36.0 | ) | (6,630 | ) | (23.3 | ) | (9,495 | ) | (34.4 | ) | ||||||||||||||||
| Interest income | 301 | 2.1 | 213 | 1.5 | 636 | 2.2 | 387 | 1.4 | ||||||||||||||||||||||||
| Interest expense | (124 | ) | (.9 | ) | (109 | ) | (.8 | ) | (236 | ) | (.8 | ) | (225 | ) | (.8 | ) | ||||||||||||||||
| Interest expense-financing fees | (21 | ) | (.1 | ) | (16 | ) | (.1 | ) | (41 | ) | (.1 | ) | (29 | ) | (.1 | ) | ||||||||||||||||
| Other | 155 | 1.0 | 1 | — | 188 | .7 | 2 | — | ||||||||||||||||||||||||
| Loss from continuing operations before taxes | (2,583 | ) | (17.7 | ) | (4,946 | ) | (35.4 | ) | (6,083 | ) | (21.3 | ) | (9,360 | ) | (33.9 | ) | ||||||||||||||||
| Income tax benefit | — | — | (1,161 | ) | (8.3 | ) | — | — | (2,117 | ) | (7.7 | ) | ||||||||||||||||||||
| Loss from continuing operations | $ | (2,583 | ) | (17.7 | ) | $ | (3,785 | ) | (27.1 | ) | $ | (6,083 | ) | (21.3 | ) | $ | (7,243 | ) | (26.2 | ) | ||||||||||||
Revenues
Consolidated revenues increased $600,000 for the three months ended June 30, 2025, compared to the three months ended June 30, 2024, as follows:
| (In thousands) | 2025 | % Revenue | 2024 | % Revenue | Change | % Change | ||||||||||||||||||
| Treatment | ||||||||||||||||||||||||
| Government waste | $ | 7,196 | 49.3 | $ | 5,645 | 40.4 | $ | 1,551 | 27.5 | |||||||||||||||
| Hazardous/non-hazardous (1) | 1,406 | 9.6 | 1,293 | 9.2 | 113 | 8.7 | ||||||||||||||||||
| Other nuclear waste | 2,795 | 19.2 | 1,405 | 10.1 | 1,390 | 98.9 | ||||||||||||||||||
| Total | 11,397 | 78.1 | 8,343 | 59.7 | 3,054 | 36.6 | ||||||||||||||||||
| Services | ||||||||||||||||||||||||
| Nuclear services | 1,681 | 11.5 | 4,426 | 31.6 | (2,745 | ) | (62.0 | ) | ||||||||||||||||
| Technical services | 1,508 | 10.4 | 1,217 | 8.7 | 291 | 23.9 | ||||||||||||||||||
| Total | 3,189 | 21.9 | 5,643 | 40.3 | (2,454 | ) | (43.5 | ) | ||||||||||||||||
| Total | $ | 14,586 | 100.0 | $ | 13,986 | 100.0 | $ | 600 | 4.3 | |||||||||||||||
(1) Includes wastes generated by government clients of $567,000 and $608,000 for the three months ended June 30, 2025, and the corresponding period of 2024, respectively.
Treatment Segment overall revenue increased by $3,054,000 or 36.6% for the three months ended June 30, 2025, over the same period in 2024. The overall increase in revenue in the Treatment Segment was primarily due to higher waste volume and higher averaged price waste from waste mix. Our Treatment Segment revenue was also positively impacted by our international initiatives, which resulted in an increase in revenue of approximately $558,000 or 150.8% in revenue as compared to the same period of last year. Services Segment revenue decreased by approximately $2,454,000 or 43.5%. The decrease in revenue in the Services Segment was due to reasons as discussed in the “Overview” section. Additionally, our Services Segment revenues are project based; as such, the scope, duration, and completion of each project vary.
| 27 |
Consolidated revenues increased $902,000 for the six months ended June 30, 2025, as compared to the six months ended June 30, 2024, as follows:
| (In thousands) | 2025 | % Revenue | 2024 | % Revenue | Change | % Change | ||||||||||||||||||
| Treatment | ||||||||||||||||||||||||
| Government waste | $ | 14,213 | 49.8 | $ | 10,778 | 39.1 | $ | 3,435 | 31.9 | |||||||||||||||
| Hazardous/non-hazardous (1) | 2,473 | 8.7 | 2,630 | 9.5 | (157 | ) | (6.0 | ) | ||||||||||||||||
| Other nuclear waste | 3,897 | 13.7 | 3,644 | 13.2 | 253 | 6.9 | ||||||||||||||||||
| Total | 20,583 | 72.2 | 17,052 | 61.8 | 3,531 | 20.7 | ||||||||||||||||||
| Services | ||||||||||||||||||||||||
| Nuclear services | 5,055 | 17.7 | 8,995 | 32.6 | (3,940 | ) | (43.8 | ) | ||||||||||||||||
| Technical services | 2,867 | 10.1 | 1,556 | 5.6 | 1,311 | 84.3 | ||||||||||||||||||
| Total | 7,922 | 27.8 | 10,551 | 38.2 | (2,629 | ) | (24.9 | ) | ||||||||||||||||
| Total | $ | 28,505 | 100.0 | $ | 27,603 | 100.0 | $ | 902 | 3.3 | |||||||||||||||
(1) Includes wastes generated by government clients of $1,007,000 and $1,236,000 for the six months ended June 30, 2025, and the corresponding period of 2024, respectively.
Treatment Segment overall revenue increased by $3,531,000 or 20.7% for the three months ended June 30, 2025, over the same period in 2024. The overall increase in revenue in the Treatment Segment was primarily due to higher waste volume and higher averaged price waste from waste mix. Our Treatment Services Segment revenue was also positively impacted by our international initiatives, which resulted in an increase in revenue of approximately $2,580,000 or 315.8% as compared to the same period of last year. Services Segment revenue decreased by approximately $2,629,000 or 24.9%. The decrease in revenue in the Services Segment was due to reasons as discussed in the “Overview” section. Additionally, our Services Segment revenues are project based; as such, the scope, duration, and completion of each project vary.
Cost of Goods Sold
Cost of goods sold decreased $2,253,000 for the quarter ended June 30, 2025, as compared to the quarter ended June 30, 2024, as follows:
| % | % | |||||||||||||||||||
| (In thousands) | 2025 | Revenue | 2024 | Revenue | Change | |||||||||||||||
| Treatment | $ | 9,831 | 86.3 | $ | 9,540 | 114.3 | $ | 291 | ||||||||||||
| Services | 3,208 | 100.6 | 5,752 | 101.9 | (2,544 | ) | ||||||||||||||
| Total | $ | 13,039 | 89.4 | $ | 15,292 | 109.3 | $ | (2,253 | ) | |||||||||||
Cost of goods sold for the Treatment Segment increased by approximately $291,000 or 3.1%. Treatment Segment’s overall fixed costs were higher by approximately $682,000 resulting from the following: salaries and payroll related expenses were higher by approximately $665,000 due to additional headcount; maintenance expenses were higher by approximately $38,000; depreciation expenses were higher by $25,000; travel expense were higher by $21,000; general expenses were higher by $11,000; and regulatory expenses were lower by $78,000. Treatment Segment’s variable costs decreased by approximately $391,000 primarily due to lower disposal costs of $758,000 and lower outside services costs of $86,000, offset by overall higher material and supplies, transportation and other costs of approximately $453,000. Within our Treatment Segment, variable cost categories can fluctuate based on waste mix. Services Segment cost of goods sold decreased $2,544,000 or 44.2% primarily due to lower revenue. The decrease in cost of goods sold was primarily due to overall lower salaries/payroll related, outside services, and travel costs totaling approximately $2,500,000; lower regulatory costs of $24,000; lower general expenses of $13,000 in various categories; and lower depreciation expense of approximately $7,000. Included within cost of goods sold is depreciation and amortization expense of $423,000 and $405,000 for the three months ended June 30, 2025, and 2024, respectively.
Cost of goods sold decreased $3,228,000 for the six months ended June 30, 2025, as compared to the six months ended June 30, 2024, as follows:
| % | % | |||||||||||||||||||
| (In thousands) | 2025 | Revenue | 2024 | Revenue | Change | |||||||||||||||
| Treatment | $ | 18,767 | 91.2 | $ | 18,301 | 107.3 | $ | 466 | ||||||||||||
| Services | 7,534 | 95.1 | 11,228 | 106.4 | (3,694 | ) | ||||||||||||||
| Total | $ | 26,301 | 92.3 | $ | 29,529 | 107.0 | $ | (3,228 | ) | |||||||||||
| 28 |
Cost of goods sold for the Treatment Segment increased by approximately $466,000 or 2.5%. Treatment Segment’s overall fixed costs were higher by approximately $1,225,000 resulting from the following: salaries and payroll related expenses were higher by $1,221,000 due to higher headcount. Additionally, salaries and payroll related expenses were higher in the first six months of 2025 as more employees took vacation time in the first six months of 2024 resulting in more hours charged to vacation accrual account; general expenses were higher by $124,000 primarily due to higher utility costs; maintenance expenses were higher by approximately $52,000; depreciation expenses were higher by $42,000; and regulatory expenses were lower by approximately $218,000. Treatment Segment’s variable costs decreased by approximately $759,000 primarily due to lower disposal costs of $2,107,000 and lower outside services costs of $79,000, offset by overall higher material and supplies, transportation and other costs of approximately $1,427,000. Within our Treatment Segment, variable cost categories can fluctuate based on waste mix. Services Segment cost of goods sold decreased $3,694,000 or 32.9% primarily due to lower revenue. The decrease in cost of goods sold was primarily due to overall lower salaries/payroll related, outside services, and travel costs totaling approximately $4,012,000; lower depreciation expenses totaling approximately $8,000; lower regulatory costs of $39,000; lower general expenses of approximately $104,000 in various categories; and overall higher material and supplies, lab and disposal costs totaling approximately $469.000. Included within cost of goods sold is depreciation and amortization expense of $845,000 and $810,000 for the six months ended June 30, 2025, and 2024, respectively.
Gross Profit (Loss)
Gross profit for the quarter ended June 30, 2025, increased $2,853,000 over the same period in 2024, as follows:
| % | % | |||||||||||||||||||
| (In thousands) | 2025 | Revenue | 2024 | Revenue | Change | |||||||||||||||
| Treatment | $ | 1,566 | 13.7 | $ | (1,197 | ) | (14.3 | ) | $ | 2,763 | ||||||||||
| Services | (19 | ) | (0.6 | ) | (109 | ) | (1.9 | ) | 90 | |||||||||||
| Total | $ | 1,547 | 10.6 | $ | (1,306 | ) | (9.3 | ) | $ | 2,853 | ||||||||||
Treatment Segment gross profit increased by $2,763,000 or approximately 230.8% and gross margin increased to 13.7% % from (14.3)% primarily due to higher revenue from higher waste volume and higher averaged price from waste mix. The increase in fixed costs within the Treatment Segment negatively impacted gross profit and gross margin. Services Segment gross profit increased by $90,000 or approximately 82.6% and gross margin improved slightly from (1.9)% to (0.6)%. The increases were attributed primarily to overall improved margin on projects and lower fixed costs which were offset by the impact of lower revenue. Our Services Segment gross margin is impacted by our current projects which are competitively bid on and will therefore, have varying margin structures.
Gross profit for the six months ended June 30, 2025, increased $4,130,000 over 2024, as follows:
| % | % | |||||||||||||||||||
| (In thousands) | 2025 | Revenue | 2024 | Revenue | Change | |||||||||||||||
| Treatment | $ | 1,816 | 8.8 | $ | (1,249 | ) | (7.3 | ) | $ | 3,065 | ||||||||||
| Services | 388 | 4.9 | (677 | ) | (6.4 | ) | 1,065 | |||||||||||||
| Total | $ | 2,204 | 7.7 | $ | (1,926 | ) | (7.0 | ) | $ | 4,130 | ||||||||||
Treatment Segment gross profit increased by $3,065,000 or approximately 245.4% and gross margin increased to 8.8% % from (7.3)% primarily due to higher revenue from higher waste volume and higher averaged price from waste mix. The increase in fixed costs within the Treatment Segment negatively impacted gross profit and gross margin. Services Segment gross profit increased by $1,065,000 or approximately 157.3% and gross margin improved from (6.4)% to 4.9%. Similar to the second quarter of 2025, the increases were attributed primarily to overall improved margin on projects and lower fixed costs which were offset by the impact of lower revenue. Our Services Segment gross margin is impacted by our current projects which are competitively bid on and will therefore, have varying margin structures.
| 29 |
SG&A
SG&A expenses increased $675,000 for the three months ended June 30, 2025, as compared to the corresponding period for 2024, as follows:
| (In thousands) | 2025 | % Revenue | 2024 | % Revenue | Change | |||||||||||||||
| Administrative | $ | 1,957 | — | $ | 1,714 | — | $ | 243 | ||||||||||||
| Treatment | 1,350 | 11.8 | 1,075 | 12.9 | 275 | |||||||||||||||
| Services | 823 | 25.8 | 666 | 11.8 | 157 | |||||||||||||||
| Total | $ | 4,130 | 28.3 | $ | 3,455 | 24.7 | $ | 675 | ||||||||||||
Administrative SG&A expenses were higher primarily due to higher salaries, payroll related expenses and stock option compensation expenses totaling approximately $105,000. The hiring of the Company’s new COO in January 2025 contributed to this increase. The remaining higher expenses in Administrative SG&A expenses were primarily due to higher outside services expenses of approximately $103,000 from more consulting and business matters, higher general expenses by approximately $19,000 in various categories and higher travel expenses of approximately $16,000 due to more travel by senior management. Treatment Segment SG&A expenses were higher primarily due to the following: salaries and payroll related expenses were higher by approximately $210,000 as more employee hours were allocated to marketing initiatives of our new PFAS technology and overall business development; bad debt expenses were higher by approximately $29,000; general expense were higher by approximately $39,000 in various categories; travel expenses were slightly higher by $7,000; and outside services expenses were lower by approximately $10,000. Services Segment SG&A expenses were higher primarily due to the following: salaries and payroll related expenses were higher by approximately $146,000 as more employee hours were spent on bid and proposals; general expenses were higher by approximately $17,000 in various categories; and travel expense were slightly lower by approximately $6,000. Included in SG&A expenses is depreciation and amortization expense of $14,000 and $25,000 for the three months ended June 30, 2025, and 2024, respectively.
SG&A expenses increased $1,146,000 for the six months ended June 30, 2025, as compared to the corresponding period for 2024, as follows:
| (In thousands) | 2025 | % Revenue | 2024 | % Revenue | Change | |||||||||||||||
| Administrative | $ | 3,880 | — | $ | 3,401 | — | $ | 479 | ||||||||||||
| Treatment | 2,706 | 13.1 | 2,140 | 12.5 | 566 | |||||||||||||||
| Services | 1,559 | 19.7 | 1,458 | 13.8 | 101 | |||||||||||||||
| Total | $ | 8,145 | 28.6 | $ | 6,999 | 25.4 | $ | 1,146 | ||||||||||||
Administrative SG&A expenses were higher primarily due to higher salaries, payroll related expenses and stock option compensation expenses totaling approximately $203,000. The hiring of the Company’s new COO in January 2025 contributed to this increase. Additionally, salaries and payroll related expenses were higher in the first six months of 2025 as more employees took vacation time in the first six months of 2024 resulting in more hours charged to vacation accrual account. The remaining higher expenses in Administrative SG&A expenses were primarily due to higher outside services expenses by approximately $228,000 from more legal, consulting and business matters, higher general expenses of approximately $21,000 in various categories and higher travel expenses of approximately $27,000 due to more travel by senior management. Treatment Segment SG&A expenses were higher primarily due to the following: salaries and payroll related expenses were higher by approximately $414,000 as more employee hours were allocated to marketing initiatives of our new PFAS technology and overall business development; bad debt expenses were higher by approximately $31,000; general expense were higher by approximately $120,000 in various categories (which include higher tradeshow expense of approximately $53,000); travel expenses were higher by $11,000; and outside services expenses were lower by approximately $10,000. Services Segment SG&A expenses were higher primarily due to the following: salaries and payroll related expenses were higher by approximately $29,000 as more employee hours were spent on bid and proposals in the second quarter of 2025 as discussed above; general expenses were higher by approximately $41,000 in various categories; outside services expenses were higher by approximately $29,000 due to more consulting matters; and travel expense were slightly higher by approximately $2,000. Included in SG&A expenses is depreciation and amortization expense of $28,000 and $52,000 for the six months ended June 30, 2025, and 2024, respectively.
| 30 |
Interest Income
Interest income increased by approximately $88,000 and $249,000 for the three and six months ended June 30, 2025, respectively, as compared to the corresponding period of 2024 primarily due to higher interest income earned from funds deposited into our money market deposit account (“MMDA”) from the two equity raises that were completed in May 2024 and December 2024.
Income Taxes
We had income tax expense of $0 and income tax benefit of $1,161,000 for continuing operations for the three months ended June 30, 2025, and the corresponding period of 2024, respectively, and income tax expense of $0 and income tax benefit of $2,117,000 for continuing operations for the six months ended June 30, 2025, and the corresponding period of 2024, respectively. Our effective tax rates were approximately 0% and 23.5% for the three months ended June 30, 2025, and the corresponding period of 2024, respectively, and 0% and 22.6% for the six months ended June 30, 2025, and the corresponding period of 2024, respectively. Our effective tax rates for the three and six months ended June 30, 2025, were impacted by our recognition of a full valuation allowance against our U.S federal and state deferred tax assets in the quarter ended September 30, 2024. Our effective tax rates for the three and six months ended June 30, 2024, were impacted by non-deductible expenses and state taxes.
On July 4, 2025, the United States enacted tax reform legislation through the “One Big Beautiful Bill Act,” which changes existing U.S. tax laws, including extending or making permanent certain provisions of the Tax Cuts and Jobs Act, repealing certain clean energy initiatives, in addition to other changes. We continue to evaluate the impact the new legislation will have on our consolidated financial statements but does not anticipate a significant impact due to our valuation allowance position, among other things.
Liquidity and Capital Resources
Our cash flow requirements during the six months ended June 30, 2025, were financed by our Liquidity (defined under our Loan Agreement as borrowing availability under the revolving credit plus cash in our MMDA maintained with our lender). Our MMDA consist of cash received in connection with the sale of our Common Stock completed in 2024 as discussed below under “Financing Activities.” We believe our cash flow requirements for the next twelve months will consist primarily of general working capital needs, scheduled principal payments on our debt obligations, remediation projects, R&D on our PFAS technology and capital expenditures (which include our PFAS technology) (see “Known Trends and Uncertainties – New Processing Technology” within this MD&A for a discussion of this technology). We plan to fund these requirements from our operations and our Liquidity. We are continually reviewing operating costs and reviewing the possibility of further reducing operating costs and non-essential expenditures to bring them in line with revenue levels. As of June 30, 2025, we had no outstanding borrowing under our Revolving Credit and our Liquidity was approximately $25,440,000. We believe that our cash flows from operations and our Liquidity should be sufficient to fund our operations for the next twelve months. Although we believe our operations should improve in the remainder of 2025, if we continue to incur losses such as in the first and second quarters of 2025, this could cause a reduction in our Liquidity.
| 31 |
The following table reflects the cash flow activities during the first six months of 2025 and 2024.
| Six Months Ended | ||||||||
| June 30, | ||||||||
| (In thousands) | 2025 | 2024 | ||||||
| Cash used in operating activities of continuing operations | $ | (3,773 | ) | $ | (5,570 | ) | ||
| Cash used in operating activities of discontinued operations | (222 | ) | (245 | ) | ||||
| Cash used in investing activities of continuing operations | (1,473 | ) | (1,342 | ) | ||||
| Cash used in investing activities of discontinued operations | (16 | ) | (49 | ) | ||||
| Cash (used in) provided by financing activities of continuing operations | (626 | ) | 18,127 | |||||
| Effect of exchange rate changes in cash | 1 | (1 | ) | |||||
| Decreaes (increase) in cash and finite risk sinking fund (restricted cash) | $ | (6,109 | ) | $ | 10,920 | |||
As of June 30, 2025, we were in a positive cash position with no revolving credit balance. As of June 30, 2025, we had cash on hand of approximately $22,594,000.
Operating Activities
Cash used in operating activities of our continuing operations during the first six months of 2025 consisted mostly of the significant net loss that we incurred of approximately $6,083,000, adjusted for certain non-cash items, such as $382,000 of stock-based compensation expenses and $873,000 of depreciation and amortization expenses. Cash flow increase of approximately $738,000 resulting from net change in assets and liabilities reflects a decrease in accounts receivable (net of provision for credit losses) of $2,974,000, a net decrease in inventories, prepaids and other assets totaling approximately of $463,000, offset by an increase in unbilled receivables of $1,297,000 and a net decrease in accounts payable, accrued expenses, deferred revenue and other accruals totaling approximately $1,402,000. Our accounts receivables are impacted by timing of invoicing and collections. Our contracts with our customers are subject to various payment terms and conditions.
Cash used in operating activities of our continuing operations during the first six months of 2024 consisted primarily of the significant net loss that we incurred of approximately $7,243,000, adjusted for certain non-cash items, which included $284,000 of stock-based compensation expenses, $862,000 of depreciation and amortization expense and deferred income tax benefit of $2,117,000. Cash flow increase of approximately $2,388,000 resulting from net change in assets and liabilities included a net decrease in accounts receivable (net of recovery in credit losses) and unbilled receivables totaling approximately $4,667,000, a net decrease in inventories and prepaid and other assets totaling approximately of $1,670,000, offset by a net decrease in accounts payables, accrued expenses, deferred revenue and other accruals totaling approximately $3,949,000.
Cash used in operating activities of our discontinued operations in the first six months of 2025 and 2024 consisted primarily of expenses incurred in connection with management and administration of regulatory matters for the Company’s remediation projects.
We had working capital of $21,481,000 (which included working capital of our discontinued operations) as of June 30, 2025, as compared to working capital of $28,283,000 as of December 31, 2024. The decrease in our working capital was primarily due to the losses incurred from our operations during the six months of 2025 as previously discussed.
Investing Activities
Cash used in investing activities of our continuing operations in the first six months of 2025 consisted mostly of our purchases of property and equipment totaling approximately $1,564,000, of which $132,000 was financed. The remaining cash used in investing activities consisted of cash outlays made in connection with our operating permits and certain intangible assets. Total cash used in investing activities of our continuing operations was partially offset by approximately $33,000 from our sale of idle equipment.
| 32 |
Cash used in investing activities of our discontinued operations in the first six months of 2025 consisted of payments made in connection with a certain regulatory permit at our PFSG subsidiary.
Cash used in investing activities of our continuing operations in the first six months of 2024 consisted mostly of our purchases of property and equipment totaling approximately $885,000, of which $44,000 was financed. The remaining cash used in investing activities of $502,000 consisted of cash outlays made in connection with our operating permits and certain intangible assets.
Cash used in investing activities of our discontinued operations in the first six months of 2024 consisted of payments made for roof replacement at our PFSG location.
The increase in our purchases of property and equipment in the six months ended June 30, 2025, as compared to the corresponding period of 2024 was primarily due to capital expenditures made in connection with our PFAS technology and plant improvements and equipment purchases related to increased productivity and safety measures.
Capital Expenditures
We anticipate making capital expenditures of approximately up to $6,000,000 for the twelve months ended December 31, 2025, to maintain operations and regulatory compliance requirements and support revenue growth. Our anticipated capital expenditures for 2025 include certain strategic project initiatives which include the installation of our second generation unit for our PFAS technology (see “Known Trends and Uncertainties – New Processing Technology”). We plan to fund our capital expenditures for 2025 from cash from operations, Liquidity and/or financing. The initiation and timing of our capital expenditures in 2025 are subject to a number of factors which include, among other things, cost/benefit analysis, the pace of our strategic project initiatives and improvement in our operations.
Financing Activities
Our cash used in financing during the first six months of 2025 consisted mostly of principal payments of approximately $313,000 primarily for our Term and Capital Loans under our Credit Facility (see below for a discussion of our Credit Facility) principal payments of $148,000 for our finance leases, payments of $194,000 of offering costs from the equity raise that we completed in December 2024, partially offset by proceeds received from option exercises of approximately $49,000.
As previously reported, during 2024, we had two offerings of our Common Stock which increased our cash position. As discussed below, in May 2024, we had the first offering. In December 2024, we completed the second securities offering in which we received net proceeds of approximately $23,208,000 after deducting offering fees and expenses.
Our cash provided in financing during the first six months of 2024 consisted primarily of net proceeds of $18,636,000 received from the sale of our Common Stock in May 2024 and proceeds received from option and warrant exercises totaling approximately $218,000, partially offset by principal payments of approximately $520,000 for our Term and Capital Loans under our Credit Facility and principal payments of $146,000 for our finance leases.
Credit Facility
We entered into a Second Amended and Restated Revolving Credit, Term Loan and Security Agreement, dated May 8, 2020, which has since been amended, with PNC National Association (“PNC” and “lender”), acting as agent and lender (the “Loan Agreement”). The Loan Agreement provides us with a credit facility with a maturity date of May 15, 2027 (the “Credit Facility”) which consists of the following as of June 30, 2025: (a) up to $12,500,000 revolving credit (“Revolving Credit”), which borrowing capacity is subject to eligible receivables (as defined) and reduced by outstanding standby letters of credit ($3,200,000 as of June 30, 2025) and borrowing reductions that our lender may impose from time to time ($750,000 as of June 30, 2025); (b) a term loan (“Term Loan”) of $2,500,000, requiring monthly installments of $41,667; and (c) a capital expenditure loan (“Capital Loan”) of approximately $524,000, requiring monthly installments of principal of approximately $8,700 plus interest.
| 33 |
On March 11, 2025, we entered into an amendment to our Loan Agreement with our lender which provided the following, among other things:
| ● | removed the quarterly fixed charge coverage ratio (“FCCR”) covenant testing requirement utilizing a twelve-month trailing basis; however, such FCCR testing requirement will be triggered on the day we fail to meet a minimum of $5,000,000 in daily Liquidity. If triggered, we will be required to show compliance of an FCCR ratio of not less than 1.15 to 1.00 utilizing a trailing twelve-month-period ended starting with the most recently reported fiscal quarter and each fiscal quarter thereafter. The FCCR testing requirement can be removed again once we are able to achieve a minimum of $5,000,000 in daily Liquidity for a thirty-consecutive-day period from the trigger date; | |
| ● | revised the Facility Fee (as defined) from .375% to .500%. Such fee percentage will revert back to .375% at such time that we are able to achieve a minimum 1.15 to 1.00 ratio in FCCR on a twelve-month trailing basis; and | |
| ● | required payment of an amendment fee of $12,500 by the Company, which is being amortized over the remaining term of the Loan Agreement as interest expense-financing fees. |
Our Loan Agreement, as amended, with PNC, contains certain financial covenant requirements, along with customary representations and warranties. A breach of any of these financial covenant requirements, unless waived by PNC, could result in a default under our Loan Agreement allowing our lender to immediately require the repayment of all outstanding debt under our Loan Agreement and terminate all commitments to extend further credit. We met all of our financial covenant requirements in the first and second quarters of 2025. We expect to meet our covenant requirements under our Loan Agreement for the next twelve months.
Off Balance Sheet Arrangements
From time to time, we are required to post standby letters of credit and various bonds to support contractual obligations to customers and other obligations, including facility closures. As of June 30, 2025, the total amount of standby letters of credit outstanding totaled approximately $3,200,000 and the total amount of bonds outstanding totaled approximately $21,044,000. We also provide closure and post-closure requirements through a financial assurance policy for certain of our Treatment Segment facilities through AIG. As of June 30, 2025, the closure and post-closure requirements for these facilities were approximately $23,951,000.
Critical Accounting Policies and Estimates
There were no significant changes in our accounting policies or critical accounting estimates that are discussed in our Annual Report on Form 10-K for the year ended December 31, 2024.
Recent Accounting Pronouncements
See “Note 2 – Summary of Significant Accounting Policies” in the “Notes to Condensed Consolidated Financial Statements” for the recent accounting pronouncement that was adopted in the first six months of 2025 and recent accounting pronouncements that will be adopted in future periods.
Known Trends and Uncertainties
Significant Customers. The contracts that we are a party to with others as subcontractors to the federal government or directly with the federal government generally provide that the government may terminate the contract at any time for convenience at the government’s option. Our inability to continue under existing contracts that we have with the federal government authorities (directly or indirectly as a subcontractor) or significant reductions in the level of governmental funding in any given year could have a material adverse impact on our operations and financial condition. We performed services relating to waste generated by federal government clients, either indirectly as a subcontractor or directly as a prime contractor to federal government entities, representing approximately $9,204,000 or 63.1% and $17,609,000 or 61.8% of our total revenues during the three and six months ended June 30, 2025, respectively, as compared to $9,669,000 or 69.1% and $18,699,000 or 67.7% of our total revenues during the corresponding period of 2024.
Federal Funding. As previously disclosed, a significant portion of our revenue is generated through contracts entered into indirectly as subcontractors for prime contractors or directly as a prime contractor to federal government. Government funding levels in general have uncertainties associated with planned federal projects and procurements. Our results of operations in the first half of 2025 were adversely impacted in part, by delays in procurements which, we believe, resulted directly from changes in the administration and supporting policies. We anticipate these changes should stabilize in the near future as new leadership within the DOE and other primary federal clients nominate and confirm leadership into each agency. Although we believe the recently proposed White House Budget and subsequent OMB (The Office of Management and Budget) published funding levels do not appear to suggest significant impacts to opportunities for the Company, we continue to be subjected to changes in spending priorities of government entities that we do business with which could negatively impact our financial results by impairing our ability to perform work on existing contracts, delaying or cancelling procurement actions and waste shipments by government entities, and /or cause other disruptions or delays.
| 34 |
Market Trends and Uncertainties. Macroeconomic conditions which include recent government and policy changes implemented in the United States, tariff actions and uncertainties related to trade wars, ambiguity around interest rates, softening labor markets, have created significant uncertainty in the global economy, volatility in the capital markets and recessionary pressures. We continue to monitor potential effects from these conditions that could impact our revenue and profitability which include supply chain challenges, cost volatility in goods that we utilize in our revenue production, and economic pressures on our customers that may result in reduced spending. While we have experienced limited impact from these conditions at this time, we continue to evaluate and implement a range of strategic options which we believe will assist us to manage potential impacts from these factors, including supply chain optimization, pricing strategies, sourcing adjustments and cost reduction measures in order to minimize impacts to our financial results.
New Processing Technology. We have completed the fabrication, installation, commissioning and startup of our first full scale commercial Perma-FAS system (“System”) for PFAS destruction, located at our Perma-Fix Florida, Inc. facility. PFAS, commonly known as “forever chemicals,” is the acronym for Perfluoroalkyl and Polyfluoroalkyl Substances, a diverse group of thousands of human-made chemical pollutants that have the potential to persist in both the environment and the human body. An increasing number of studies have documented adverse health risks that are associated with PFAS exposure, including increased risks of some cancers, reduced immune function, and developmental delays in children. Commercial destruction of PFAS offers a promising new source of revenue for us, as it complements our core waste remediation technologies, and we have filed patent applications relating to our System technology for PFAS destruction. With the successful startup of our pilot System, we have already processed commercial quantities of PFAS-containing waste materials. There are limited current treatment options for these materials, and we expect that our process will exceed any of these other current methods. Some of the sizable markets for PFAS include AFFF firefighting foams, both expired concentrate and flushing liquids, contaminated liquids from PFAS systems, and other water-based separation products from a variety of industrial systems. We have already secured and are treating approximately 10,000 gallons of AFFF liquids to support ongoing operations, demonstration, and further testing of our System. We believe that we will receive an additional 50,000 gallons in the coming months.
Our strategy for our System includes continued treatment of PFAS liquids over the coming months and targeting engineering refinements to support larger-scale Systems. With significant upgrades to our prototype currently in the design phase, we anticipate deployment of the second generation unit in the fourth quarter of 2025 at one of our other existing treatment facilities. In the next several calendar quarters we expect to advance the Perma-FAS technology from demonstrated successful bench-scale testing to pilot-scale applications for soil, biosolids, and filter media, broadening the reach of our System’s PFAS destruction capabilities.
Environmental Contingencies
We are engaged in the waste management services segment of the pollution control industry. As a participant in the on-site treatment, storage and disposal market and the off-site treatment and services market, we are subject to rigorous federal, state and local regulations. These regulations mandate strict compliance and therefore are a cost and concern to us. Because of their integral role in providing quality environmental services, we make every reasonable attempt to maintain complete compliance with these regulations; however, even with a diligent commitment, we, along with many of our competitors, may be required to pay fines for violations or investigate and potentially remediate our waste management facilities.
We routinely use third party disposal companies, who ultimately destroy, or secure landfill residual materials generated at our facilities or at a client’s site. In the past, numerous third-party disposal sites have improperly managed waste and consequently require remedial action; consequently, any party utilizing these sites may be liable for some or all of the remedial costs. Despite our aggressive compliance and auditing procedures for disposal of wastes, we could further be notified, in the future, that we are a potentially responsible party (“PRP”) at a remedial action site, which could have a material adverse effect.
| 35 |
We have three environmental remediation projects, all within our discontinued operations, which principally entail the removal/remediation of contaminated soil, and, in most cases, the remediation of surrounding ground water. We expect to fund the expenses to remediate these sites from funds generated from operations. As of June 30, 2025, we had total accrued environmental remediation liabilities of $764,000, a decrease of $3,000 from the December 31, 2024 balance of $767,000. The decrease represents payments for our PFSG remediation project. As of June 30, 2025, the total balance of the accrued environmental remediation liabilities was recorded as long-term.
Item 3. Quantitative and Qualitative Disclosures about Market Risks
Not required for smaller reporting companies.
Item 4. Controls and Procedures
| (a) | Evaluation of disclosure controls and procedures. |
We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our periodic reports filed with the Securities and Exchange Commission is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission and that such information is accumulated and communicated to our management. As of the end of the period covered by this report, we conducted an evaluation with the participation of our Principal Executive Officer and Principal Financial Officer. Based on this recent assessment, our Principal Executive Officer and Principal Financial Officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended) were effective as of June 30, 2025.
|
|
| (b) | Changes in internal control over financial reporting. |
There was no other change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during our most recently completed fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. |
PART II – OTHER INFORMATION
Item 1. Legal Proceedings
There are no material legal proceedings pending against us and/or our subsidiaries not previously reported by us in Item 3 of our Form 10-K for the year ended December 31, 2024. Additionally, there has been no other material change in legal proceedings previously disclosed by us in our Form 10-Q for the quarter ended March 31, 2025.
Item 1A. Risk Factors
There has been no other material change from the risk factors previously disclosed in our Form 10-K for the year ended December 31, 2024, except as follows:
The following additional Risk Factor under “Risks Relating to our Financial Performance and Position and Need for Financing” is as follows:
We have sustained losses during the first six months of 2025.
The Company sustained losses during the first six months of 2025. We believe that our results of operations should improve starting in the second half of 2025. If, however, we fail to become profitable on an annualized basis in the foreseeable future, this could have a material adverse effect on our operations, credit facility, liquidity and potential growth.
Item 6. Exhibits
| (a) | Exhibits |
| 31.1 | Certification by Mark Duff, Chief Executive Officer of the Company pursuant to Rule 13a-14(a) or 15d-14(a). | ||
| 31.2 | Certification by Ben Naccarato, Chief Financial Officer of the Company pursuant to Rule 13a-14(a) or 15d-14(a). | ||
| 32.1 | Certification by Mark Duff, Chief Executive Officer of the Company furnished pursuant to 18 U.S.C. Section 1350. | ||
| 32.2 | Certification by Ben Naccarato, Chief Financial Officer of the Company furnished pursuant to 18 U.S.C. Section 1350. | ||
| 101.INS | XBRL Instance Document* | ||
| 101.SCH | XBRL Taxonomy Extension Schema Document* | ||
| 101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document* | ||
| 101.DEF | XBRL Taxonomy Extension Definition Linkbase Document* | ||
| 101.LAB | XBRL Taxonomy Extension Labels Linkbase Document* | ||
| 101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document* | ||
| * Pursuant to Rule 406T of Regulation S-T, the Interactive Data File in Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Section 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purpose of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections. |
| 36 |
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
| PERMA-FIX ENVIRONMENTAL SERVICES | ||
| Date: August 7, 2025 | By: | /s/ Mark Duff |
| Mark Duff | ||
| President and Chief (Principal) Executive Officer | ||
| Date: August 7, 2025 | By: | /s/ Ben Naccarato |
| Ben Naccarato | ||
| Chief (Principal) Financial Officer |
| 37 |
Source:
FAQ
How much revenue did Perma-Fix (PESI) report for Q2 2025?
Did PESI achieve profitability in the quarter?
What drove the gross margin improvement?
What is PESI鈥檚 current debt position?
How much cash does the company hold after Q2 2025?
Why did shares outstanding increase?
Which segment underperformed during the quarter?
